

 



<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
  "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml"
      xmlns:foaf="http://xmlns.com/foaf/0.1/"
      xmlns:dc="http://purl.org/dc/terms/"
      xmlns:doi="http://dx.doi.org/"
      xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
      xmlns:xsd="http://www.w3.org/2001/XMLSchema-datatypes#"
      lang="en" xml:lang="en"
      itemscope itemtype="http://schema.org/Article"
      class="no-js">
<head prefix="og: http://ogp.me/ns#">
  <title>PLOS ONE: Computer-Aided Lead Optimization: Improved Small-Molecule Inhibitor of the Zinc Endopeptidase of Botulinum Neurotoxin Serotype A</title>


<link rel="stylesheet" type="text/css"  href="/css/global-min.css?v=izteQ6tu7kgsJZW_xmrYizvKiHM" />


    <!--[if lte IE 7]>
<link rel="stylesheet" type="text/css"  href="/css/lte_ie7-min.css?v=3bykQUyQmReeuobVyPozcJ9LxRc" />
    <![endif]-->


<link rel="stylesheet" type="text/css"  href="/css/jquery-ui-min.css?v=eXDHTEJM0lIAmDe5k0I0Ad4nxNo" />


<link rel="stylesheet" type="text/css"  href="/css/journal.css?v=T7ZVxJfgk9jNxLAJ2qHz1vZpgYU" />


<link rel="stylesheet" type="text/css" media="print" href="/css/print-min.css?v=T5lb0B3q6EXBsuDluc5V5w+AkRc" />


  <link rel="stylesheet" href="http://f.fontdeck.com/s/css/js/www.plosone.org/24557.css" type="text/css"/>

  <!--chartbeat -->
  <script type="text/javascript">var _sf_startpt = (new Date()).getTime()</script>
  <script>document.documentElement.className += ' js';</script>

  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
  <meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7; IE=EmulateIE9"/>
  <meta name="description" content="PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all disciplines freely available to the whole world."/>
  <meta name="keywords" content="PLOS, Public Library of Science, Open Access, Open-Access, Science, Medicine, Biology, Research, Peer-review, Inclusive, Interdisciplinary, Ante-disciplinary, Physics, Chemistry, Engineering"/>
  <meta name="almHost" content="http://alm.plos.org/api/v3/articles"/>
  <meta name="searchHost" content="http://api.plos.org/search" />
  <meta name="termsHost" content="http://api.plos.org/terms" />
  <meta name="solrApiKey" content="plos"/>
  <meta name="almAPIKey" content="3pezRBRXdyzYW6ztfwft" />
  <meta name="currentJournal" content="PLoSONE" />
  <meta name="almRequestBatchSize" content="" />

  <meta name="citation_publisher" content="Public Library of Science"/>
  <meta name="citation_doi" content="10.1371/journal.pone.0000761"/>
  <meta name="dc.identifier" content="10.1371/journal.pone.0000761" />

    <meta name="citation_title" content="Computer-Aided Lead Optimization: Improved Small-Molecule Inhibitor of the Zinc Endopeptidase of Botulinum Neurotoxin Serotype A"/>
    <meta itemprop="name" content="Computer-Aided Lead Optimization: Improved Small-Molecule Inhibitor of the Zinc Endopeptidase of Botulinum Neurotoxin Serotype A"/>

      <meta name="citation_author" content="Jing Tang"/>
            <meta name="citation_author_institution" content="Computer-Aided Molecular Design Laboratory, Mayo Clinic, Rochester, Minnesota, United States of America"/>
      <meta name="citation_author" content="Jewn Giew Park"/>
            <meta name="citation_author_institution" content="Computer-Aided Molecular Design Laboratory, Mayo Clinic, Rochester, Minnesota, United States of America"/>
      <meta name="citation_author" content="Charles B. Millard"/>
            <meta name="citation_author_institution" content="Division of Biochemistry, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America"/>
      <meta name="citation_author" content="James J. Schmidt"/>
            <meta name="citation_author_institution" content="Department of Cell Biology and Biochemistry, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America"/>
      <meta name="citation_author" content="Yuan-Ping Pang"/>
            <meta name="citation_author_institution" content="Computer-Aided Molecular Design Laboratory, Mayo Clinic, Rochester, Minnesota, United States of America"/>

    <meta name="citation_date" content="2007/8/22"/>

  <meta name="citation_pdf_url" content="http://dx.plos.org/10.1371/journal.pone.0000761.pdf" />

      <meta name="citation_journal_title" content="PLOS ONE" />
    <meta name="citation_firstpage" content="e761"/>
    <meta name="citation_issue" content="8"/>
    <meta name="citation_volume" content="2"/>
    <meta name="citation_issn" content="1932-6203"/>

    <meta name="citation_journal_abbrev" content="PLoS ONE" />

      <meta name="citation_reference" content="citation_title=Botulism in the United States-a clinical and epidemiologic review.; citation_author=RL Shapiro; citation_author=C Hatheway; citation_author=DL Swerdlow; citation_journal_title=Ann Intern Med; citation_volume=129; citation_number=1; citation_pages=221-228; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=Botulinum toxin—from poison to remedy.; citation_author=KR Kessler; citation_author=R Benecke; citation_journal_title=Neurotoxicology; citation_volume=18; citation_number=2; citation_pages=761-770; citation_date=1997; " />
      <meta name="citation_reference" content="citation_title=The Botox boom.; citation_author=K Springen; citation_author=J Raymond; citation_author=C Skipp; citation_author=JSS Scelfo; citation_journal_title=Newsweek; citation_number=3; citation_pages=50-58; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Intimate details of the most poisonous poison.; citation_author=BR Singh; citation_journal_title=Nat Struct Biol; citation_volume=7; citation_number=4; citation_pages=617-619; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=The origin, structure, and pharmacological activity of botulinum toxin.; citation_author=LL Simpson; citation_journal_title=Pharmacol Rev; citation_volume=33; citation_number=5; citation_pages=155-188; citation_date=1981; " />
      <meta name="citation_reference" content="citation_title=Novel small molecule inhibitors of botulinum neurotoxin A metalloprotease activity.; citation_author=JC Burnett; citation_author=JJ Schmidt; citation_author=RG Stafford; citation_author=RG Panchal; citation_author=TL Nguyen; citation_journal_title=Biochem Biophys Res Commun; citation_volume=310; citation_number=6; citation_pages=84-93; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Serotype-selective, small-molecule inhibitors of the zinc endopeptidase of botulinum neurotoxin serotype A. Bioorg Med Chem; citation_author=JG Park; citation_author=PC Sill; citation_author=EF Makiyi; citation_author=AT Garcia-Sosa; citation_author=CB Millard; citation_volume=14; citation_number=7; citation_pages=395-408; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Identification of a botulinum neurotoxin A protease inhibitor displaying efficacy in a cellular model.; citation_author=GE Boldt; citation_author=LM Eubanks; citation_author=KD Janda; citation_journal_title=Chem Commun (Camb); citation_number=8; citation_pages=3063-3065; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Synthesis, characterization and development of a high-throughput methodology for the discovery of botulinum neurotoxin a inhibitors.; citation_author=GE Boldt; citation_author=JP Kennedy; citation_author=MS Hixon; citation_author=LA McAllister; citation_author=JT Barbieri; citation_journal_title=J Comb Chem; citation_volume=8; citation_number=9; citation_pages=513-521; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Identification of a potent botulinum neurotoxin a protease inhibitor using in situ lead identification chemistry.; citation_author=GE Boldt; citation_author=JP Kennedy; citation_author=KD Janda; citation_journal_title=Org Lett; citation_volume=8; citation_number=10; citation_pages=1729-1732; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=The use of small molecules to investigate molecular mechanisms and therapeutic targets for treatment of botulinum neurotoxin A intoxication.; citation_author=TJ Dickerson; citation_author=KD Janda; citation_journal_title=Chem Biol; citation_volume=1; citation_number=11; citation_pages=359-369; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Bis-imidazoles as molecular probes for peripheral sites of the zinc endopeptidase of botulinum neurotoxin serotype A.; citation_author=I Merino; citation_author=JD Thompson; citation_author=CB Millard; citation_author=JJ Schmidt; citation_author=Y-P Pang; citation_journal_title=Bioorg Med Chem; citation_volume=14; citation_number=12; citation_pages=3583-3591; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Structure- and fragment-based approaches to protease inhibition.; citation_author=SL Johnson; citation_author=M Pellecchia; citation_journal_title=Curr Top Med Chem; citation_volume=6; citation_number=13; citation_pages=317-329; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonists.; citation_author=LM Eubanks; citation_author=MS Hixon; citation_author=W Jin; citation_author=S Hong; citation_author=CM Clancy; citation_journal_title=Proc Natl Acad Sci U S A; citation_number=14; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Inhibition of metalloprotease botulinum serotype A from a pseudo-peptide binding mode to a small molecule that is active in primary neurons.; citation_author=JC Burnett; citation_author=G Ruthel; citation_author=CM Stegmann; citation_author=RG Panchal; citation_author=TL Nguyen; citation_journal_title=J Biol Chem; citation_volume=282; citation_number=15; citation_pages=5004-5014; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Small-molecule inhibitors of protein-protein interactions: progressing towards the dream.; citation_author=MR Arkin; citation_author=JA Wells; citation_journal_title=Nat Rev Drug Dis; citation_volume=3; citation_number=16; citation_pages=301-317; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Substrate recognition strategy for botulinum neurotoxin serotype A.; citation_author=MA Breidenbach; citation_author=AT Brunger; citation_journal_title=Nature; citation_volume=432; citation_number=17; citation_pages=925-929; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Zinc's exclusive tetrahedral coordination governed by its electronic structure.; citation_author=RR Roe; citation_author=Y-P Pang; citation_journal_title=J Mol Model; citation_volume=5; citation_number=18; citation_pages=134-140; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Novel zinc protein molecular dynamics simulations: steps toward antiangiogenesis for cancer treatment.; citation_author=YP Pang; citation_journal_title=J Mol Model; citation_volume=5; citation_number=19; citation_pages=196-202; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Successful molecular dynamics simulation of the zinc-bound farnesyltransferase using the cationic dummy atom approach.; citation_author=YP Pang; citation_author=K Xu; citation_author=J El Yazal; citation_author=FG Prendergast; citation_journal_title=Protein Sci; citation_volume=9; citation_number=20; citation_pages=1857-1865; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Successful molecular dynamics simulation of two zinc complexes bridged by a hydroxide in phosphotriesterase using the cationic dummy atom method.; citation_author=Y-P Pang; citation_journal_title=Proteins; citation_volume=45; citation_number=21; citation_pages=183-189; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Insight into the mechanism of the IMP-1 metallo-beta-lactamase by molecular dynamics simulations.; citation_author=P Oelschlaeger; citation_author=RD Schmid; citation_author=J Pleiss; citation_journal_title=Protein Eng; citation_volume=16; citation_number=22; citation_pages=341-350; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Modeling domino effects in enzymes: molecular basis of the substrate specificity of the bacterial metallo-beta-lactamases IMP-1 and IMP-6.; citation_author=P Oelschlaeger; citation_author=RD Schmid; citation_author=J Pleiss; citation_journal_title=Biochemistry; citation_volume=42; citation_number=23; citation_pages=8945-8956; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Computational and experimental studies of (2,2)-bis(indol-1-yl-methyl)acetate suggest the importance of the hydrophobic effect in aromatic stacking interactions.; citation_author=YP Pang; citation_author=JL Miller; citation_author=PA Kollman; citation_journal_title=J Am Chem Soc; citation_volume=121; citation_number=24; citation_pages=1717-1725; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Comparison of simple potential functions for simulating liquid water.; citation_author=WL Jorgensen; citation_author=J Chandreskhar; citation_author=JD Madura; citation_author=RW Impey; citation_author=ML Klein; citation_journal_title=J Chem Phys; citation_volume=79; citation_number=25; citation_pages=926-935; citation_date=1982; " />
      <meta name="citation_reference" content="citation_title=Stereoselective synthesis of arylated (E)-alkenes by the reaction of alk-1-enylboranes with aryl halides in the presence of palladium catalyst.; citation_author=N Miyaura; citation_author=A Suzuki; citation_journal_title=J Chem Soc, Chem Commun; citation_number=26; citation_pages=866-867; citation_date=1979; " />
      <meta name="citation_reference" content="citation_title=Synthetic studies via the cross-coupling reaction of organoboron derivatives with organic halides.; citation_author=A Suzuki; citation_journal_title=Pure Appl Chem; citation_volume=63; citation_number=27; citation_pages=419-422; citation_date=1991; " />
      <meta name="citation_reference" content="citation_title=Palladium-catalyzed cross-coupling reactions of organoboron compounds.; citation_author=N Miyaura; citation_author=A Suzuki; citation_journal_title=Chem Rev; citation_volume=95; citation_number=28; citation_pages=2457-2483; citation_date=1995; " />
      <meta name="citation_reference" content="citation_title=Heterocyclic Chemistry.; citation_author=JA Joule; citation_author=K Mills; citation_author=GF Smith; citation_number=29; citation_pages=261; citation_date=1998; citation_publisher=Stanley Thornes; " />
      <meta name="citation_reference" content="citation_title=Heterocyclic Chemistry. Volume II.; citation_author=RR Gupta; citation_author=M Kumar; citation_author=V Gupta; citation_number=30; citation_pages=145-147; citation_date=1999; citation_publisher=Springer; " />
      <meta name="citation_reference" content="citation_title=Palladium catalyzed synthesis of aryl heterocyclic and vinylic acetylene derivatives.; citation_author=HA Dieck; citation_author=FR Heck; citation_journal_title=J Organomet Chem; citation_volume=93; citation_number=31; citation_pages=259-263; citation_date=1975; " />
      <meta name="citation_reference" content="citation_title=Palladium-catalyzed coupling reaction of terminal alkynes with aryl iodides in the presence of indium tribromide and its application to a one-pot synthesis of 2-phenylindole.; citation_author=N Sakai; citation_author=K Annaka; citation_author=T Konakahara; citation_journal_title=Org Lett; citation_volume=6; citation_number=32; citation_pages=1527-1530; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Synthesis and GABA receptor potency of 3-thiomethyl-4-(hetero)aryl-5-amino-1-phenylpyrazoles.; citation_author=SK Meegalla; citation_author=D Doller; citation_author=D Sha; citation_author=R Soll; citation_author=N Wisnewski; citation_journal_title=Bioorg Med Chem Lett; citation_volume=14; citation_number=33; citation_pages=4949-4953; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Improved solution- and solid-phase preparation of hydroxamic acids from esters.; citation_author=CY Ho; citation_author=E Strobel; citation_author=J Ralbovsky; citation_author=RA Galemmo; citation_journal_title=J Org Chem; citation_volume=70; citation_number=34; citation_pages=4873-4875; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=n-Pentenyl 2-amino-2-deoxy glycosides undergo stereoselective coupling under mild, chemospecific conditions.; citation_author=DR Mootoo; citation_author=B Fraiser-Reid; citation_journal_title=Tetrahedron Lett; citation_volume=30; citation_number=35; citation_pages=2363; citation_date=1989; " />
      <meta name="citation_reference" content="citation_title=Suggested improved method for the Ing-Manske and related reactions for the second step of Gabriel synthesis of primary amines.; citation_author=A Ariffin; citation_author=MN Khan; citation_author=LC Lan; citation_author=FY May; citation_author=CS Yun; citation_journal_title=Synth Commun; citation_volume=34; citation_number=36; citation_pages=4439-4445; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Endoproteinase activity of type A botulinum neurotoxin: substrate requirements and activation by serum albumin.; citation_author=JJ Schmidt; citation_author=KA Bostian; citation_journal_title=J Protein Chem; citation_volume=16; citation_number=37; citation_pages=19-26; citation_date=1997; " />
      <meta name="citation_reference" content="citation_title=Reversible enzyme inhibition.; citation_author=JA Todhunter; citation_journal_title=Methods in Enzymology; citation_volume=63; citation_number=38; citation_pages=383-411; citation_date=1979; " />
      <meta name="citation_reference" content="citation_title=Inhibition of angiotensin converting enzyme: mechanism and substrate dependence.; citation_author=R Shapiro; citation_author=JF Riordan; citation_journal_title=Biochemistry; citation_volume=23; citation_number=39; citation_pages=5225-5233; citation_date=1984; " />
      <meta name="citation_reference" content="citation_title=Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase: steps toward novel drugs for treating Alzheimer's disease.; citation_author=Y-P Pang; citation_author=P Quiram; citation_author=T Jelacic; citation_author=F Hong; citation_author=S Brimijoin; citation_journal_title=J Biol Chem; citation_volume=271; citation_number=40; citation_pages=23646-23649; citation_date=1996; " />
      <meta name="citation_reference" content="citation_title=Nonbonded bivalence approach to cell-permeable molecules that target DNA sequences.; citation_author=Y-P Pang; citation_journal_title=Bioorg Med Chem; citation_volume=12; citation_number=41; citation_pages=3063-3068; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Ab initio calculations of proton dissociation energies of zinc ligands: hypothesis of imidazolate as zinc ligand in proteins.; citation_author=J El Yazal; citation_author=YP Pang; citation_journal_title=J Phys Chem B; citation_volume=103; citation_number=42; citation_pages=8773-8779; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Zinc's affect on proton transfer between imidazole and acetate predicted by ab initio calculations.; citation_author=J El Yazal; citation_author=RR Roe; citation_author=Y-P Pang; citation_journal_title=J Phys Chem B; citation_volume=104; citation_number=43; citation_pages=6662-6667; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Comparison of DFT, Moller-Plesset, and coupled cluster calculations of the proton dissociation energies of imidazole and N-methylacetamide in the presence of zinc(II).; citation_author=J El Yazal; citation_author=YP Pang; citation_journal_title=J Mol Struct (Theochem),; citation_volume=545; citation_number=44; citation_pages=271-274; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules.; citation_author=DA Pearlman; citation_author=DA Case; citation_author=JW Caldwell; citation_author=WS Ross; citation_author=TE Cheatham; citation_journal_title=Comput Phys Commun; citation_volume=91; citation_number=45; citation_pages=1-41; citation_date=1995; " />
      <meta name="citation_reference" content="citation_title=GAUSSIAN 98, Revision A.7.; citation_author=MJ Frisch; citation_author=GW Trucks; citation_author=HB Schlegel; citation_author=PMW Gill; citation_author=BG Hohnson; citation_number=46; citation_date=1999; citation_publisher=Gaussian, Inc; " />
      <meta name="citation_reference" content="citation_title=Three-dimensional model of a substrate-bound SARS chymotrypsin-like cysteine proteinase predicted by multiple molecular dynamics simulations: catalytic efficiency regulated by substrate binding.; citation_author=Y-P Pang; citation_journal_title=Proteins; citation_volume=57; citation_number=47; citation_pages=747-757; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=A second generation force field for the simulation of proteins, nucleic acids, and organic molecules.; citation_author=WD Cornell; citation_author=P Cieplak; citation_author=CI Bayly; citation_author=IR Gould; citation_author=KM Merz; citation_journal_title=J Am Chem Soc; citation_volume=117; citation_number=48; citation_pages=5179-5197; citation_date=1995; " />
      <meta name="citation_reference" content="citation_title=Molecular dynamics with coupling to an external bath.; citation_author=HJC Berendsen; citation_author=JPM Postma; citation_author=WF van Gunsteren; citation_author=A Di Nola; citation_author=JR Haak; citation_journal_title=J Chem Phys; citation_volume=81; citation_number=49; citation_pages=3684-3690; citation_date=1984; " />
      <meta name="citation_reference" content="citation_title=Particle Mesh Ewald: An N log(N) method for Ewald sums in large systems.; citation_author=TA Darden; citation_author=DM York; citation_author=LG Pedersen; citation_journal_title=J Chem Phys; citation_volume=98; citation_number=50; citation_pages=10089-10092; citation_date=1993; " />
      <meta name="citation_reference" content="citation_title=Peptide substrate specificity and properties of the zinc-endopeptidase activity of botulinum type B neurotoxin.; citation_author=CC Shone; citation_author=AK Roberts; citation_journal_title=Eur J Biochem; citation_volume=225; citation_number=51; citation_pages=263-270; citation_date=1994; " />
      <meta name="citation_reference" content="citation_title=Fluorigenic substrates for the protease activities of botulinum neurotoxins, serotypes A, B, and F.; citation_author=JJ Schmidt; citation_author=RG Stafford; citation_journal_title=Appl Environ Microbiol; citation_volume=69; citation_number=52; citation_pages=297-303; citation_date=2003; " />

  <link rel="canonical" href="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0000761" />

    <meta name="twitter:card" content="summary"/>
    <meta name="twitter:site" content="@plosone"/>
    <meta name="twitter:title" content="Computer-Aided Lead Optimization: Improved Small-Molecule Inhibitor of the Zinc Endopeptidase of Botulinum Neurotoxin Serotype A"/>
    <meta name="twitter:description" content="Optimization of a serotype-selective, small-molecule inhibitor of botulinum neurotoxin serotype A (BoNTA) endopeptidase is a formidable challenge because the enzyme-substrate interface is unusually large and the endopeptidase itself is a large, zinc-binding protein with a complex fold that is difficult to simulate computationally. We conducted multiple molecular dynamics simulations of the endopeptidase in complex with a previously described inhibitor (Kiapp of 7&plusmn;2.4 &micro;M) using the cationic dummy atom approach. Based on our computational results, we hypothesized that introducing a hydroxyl group to the inhibitor could improve its potency. Synthesis and testing of the hydroxyl-containing analog as a BoNTA endopeptidase inhibitor showed a twofold improvement in inhibitory potency (Kiapp of 3.8&plusmn;0.8 &micro;M) with a relatively small increase in molecular weight (16 Da). The results offer an improved template for further optimization of BoNTA endopeptidase inhibitors and demonstrate the effectiveness of the cationic dummy atom approach in the design and optimization of zinc protease inhibitors."/>
      <meta name="twitter:image" content="http://dx.plos.org/10.1371/journal.pone.0000761.g005"/>

  <meta property="og:title" content="Computer-Aided Lead Optimization: Improved Small-Molecule Inhibitor of the Zinc Endopeptidase of Botulinum Neurotoxin Serotype A" />
  <meta property="og:type" content="article" />
  <meta property="og:url" content="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0000761" />

 <!--end articleInfoX-->

  <link rel="pingback" href="http://www.plosone.org/pingback" />


  <link rel="shortcut icon" href="/images/favicon.ico" type="image/x-icon"/>
  <link rel="home" title="home" href="/"/>
  <link rel="alternate" type="application/rss+xml"
        title="PLOS ONE: New Articles"
        href="http://www.plosone.org/article/feed"/>
</head>
<body>

  <div id="page-wrap">
    <div id="topbanner" class="cf">

<!-- Div for the ad at the top of journal home page-->
<div class="center">
  <div class="title">Advertisement</div>
  <iframe id='a3ac9da4' name='a3ac9da4'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=345&amp;cb=2671'
    frameborder='0' scrolling='no' width='730' height='90'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a3ac9da4&amp;cb=4489'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=345&amp;cb=4199&amp;n=a3ac9da4'
      border='0' alt=''/>
    </a>
  </iframe>
</div>    </div>

    <div id="pagehdr-wrap">
      <div id="pagehdr">
        <div id="user" class="nav">
          <ul>
            <li><a href="http://www.plos.org">plos.org</a></li>
            <li><a href="https://register.plos.org/ambra-registration/register.action">create account</a></li>
            <li class="btn-style"><a
              href="/user/secure/secureRedirect.action?goTo=%2Farticle%2FfetchArticle.action%3FarticleURI%3Dinfo%253Adoi%252F10.1371%252Fjournal.pone.0000761">sign in</a>
            </li>
          </ul>
        </div>
        <div class="logo">
          <a href="/"><img src="/images/logo.png" alt="PLOS ONE"></a>
        </div>

<div id="nav-main" class="nav">
  <ul>
        <li id="mn-01"><a href="/taxonomy" class="areas-link">Subject Areas</a></li>
    <li id="mn-02"><a href="javascript:void(0);">For Authors</a>
      <div class="submenu" style="width: 540px; margin-left: -300px;">
        <div class="block">
          <div class="submit-script">
            <h3>Submit your Manuscript</h3>
            <ul>
              <li>Fair, rigorous peer review</li>
              <li>Broad scope and wide reach</li>
            </ul>
            <a href="/static/submissionInstructions" class="btn">get started</a>
          </div>
        </div>
        <div class="menu">
          <ul>
            <li><a href="/static/publish">Why Publish with PLOS ONE</a></li>
            <li><a href="/static/publication">Publication Criteria</a></li>
            <li><a href="/static/editorial">Editorial Policies</a></li>
            <li><a href="/static/guidelines">Preparing A Manuscript</a></li>
            <li><a href="/static/figureGuidelines">Figure and Table Guidelines</a></li>
          <li><a href="/static/supportingInformation">Supporting Information Guidelines</a></li>
            <li><a href="/static/submissionInstructions">Submitting a Manuscript</a></li>
          </ul>
        </div>
      </div>
    </li>

    <li id="mn-03"><a href="javascript:void(0);">About Us</a>
      <div class="submenu" style="width:248px; margin-left:-30px;">
        <div class="menu">
          <ul>
            <li><a href="/static/information">Journal Information</a></li>
            <li><a href="/static/edboard">Editorial Board</a></li>
            <li><a href="/static/reviewerGuidelines">Reviewer Guidelines</a></li>
            <li><a href="/static/almInfo">Article-Level Metrics</a></li>
            <li><a href="/static/license">Open-Access License</a></li>
            <li><a href="/static/downloads">Media Downloads</a></li>
            <li><a href="/static/commentGuidelines">Guidelines for Comments</a></li>
            <li><a href="/static/corrections">Corrections</a></li>
            <li><a href="/static/help">Help Using this Site</a></li>
            <li><a href="/static/contact">Contact Us</a></li>
          </ul>
        </div>
      </div>
    </li>
  </ul>
<div id="db">
  <form name="searchForm" action="/search/simple?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0000761" method="get" >
<input type="hidden" name="from" value="globalSimpleSearch" id="from"/><input type="hidden" name="filterJournals" value="PLoSONE" id="filterJournals"/>    <fieldset>
      <legend>Search</legend>
      <label for="search">Search</label>
      <div class="wrap">
        <input id="search" type="text" name="query" placeholder="Search">
        <input type="image" alt="SEARCH" src="/images/icon.search.gif">
      </div>
    </fieldset>
  </form>
    <a id="advSearch" href="/search/advanced?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0000761&filterJournals=PLoSONE">advanced search</a>
</div></div>

      </div>
      <!-- pagehdr-->
    </div>
    <!-- pagehdr-wrap -->

  <!--body and html tags gets closed in global_footer.ftl-->
<script type="text/javascript" src="/javascript/mathjax/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>

<div id="pagebdy-wrap">
  <div id="pagebdy">

    <div id="article-block" class="cf">

<div class="article-meta cf">
  <ul id="almSignPost" style="display: none;"></ul>
  <div class="article-type">
    <span class="type oa">Open Access</span>
      <span class="type pr">Peer-Reviewed</span>
  </div>
</div>

<div class="header" id="hdr-article">

<div class="article-kicker">
      <span id="article-type-heading">
        Research Article
      </span>
</div>  <h1 property="dc:title" datatype="" rel="dc:type" href="http://purl.org/dc/dcmitype/Text">
    Computer-Aided Lead Optimization: Improved Small-Molecule Inhibitor of the Zinc Endopeptidase of Botulinum Neurotoxin Serotype A
  </h1>

  <ul class="authors">
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Jing Tang, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Computer-Aided Molecular Design Laboratory, Mayo Clinic, Rochester, Minnesota, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Jewn Giew Park, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Computer-Aided Molecular Design Laboratory, Mayo Clinic, Rochester, Minnesota, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Charles B. Millard, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Division of Biochemistry, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            James J. Schmidt
              <span class="corresponding">mail</span>, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              <p><span class="email">*</span>To whom correspondence should be addressed. E-mail: <a href="mailto:james.schmidt@det.amedd.army.mil">james.schmidt@det.amedd.army.mil</a> (JS); <a href="mailto:pang@mayo.edu">pang@mayo.edu</a> (Y-PP)</p>

                <p>Affiliation:
                  Department of Cell Biology and Biochemistry, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Yuan-Ping Pang
              <span class="corresponding">mail</span>
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              <p><span class="email">*</span>To whom correspondence should be addressed. E-mail: <a href="mailto:james.schmidt@det.amedd.army.mil">james.schmidt@det.amedd.army.mil</a> (JS); <a href="mailto:pang@mayo.edu">pang@mayo.edu</a> (Y-PP)</p>

                <p>Affiliation:
                  Computer-Aided Molecular Design Laboratory, Mayo Clinic, Rochester, Minnesota, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
  </ul>
  <ul class="date-doi-line">
    <li>Published: August 22, 2007</li>
    <li>DOI: 10.1371/journal.pone.0000761</li>
  </ul>


</div><!--end header-->
<div class="main cf" id="pjax-container">
  

<div class="nav items-5" id="nav-article">
  <ul>
  <li>
        <span class="active" name="article">Article</span>
  </li>
  <li>
      <a href="/article/authors/info%3Adoi%2F10.1371%2Fjournal.pone.0000761" name="authors">About the Authors</a>
  </li>
  <li>
      <a href="/article/metrics/info%3Adoi%2F10.1371%2Fjournal.pone.0000761" name="metrics">Metrics</a>
  </li>
  <li>
      <a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0000761" name="comments">Comments</a>
  </li>
  <li>
      <a href="/article/related/info%3Adoi%2F10.1371%2Fjournal.pone.0000761" name="related">Related Content</a>
  </li>
  </ul>
</div>

<script type="text/javascript">
  var selected_tab = "article";
</script>
  <div id="figure-thmbs" class="carousel cf">
    <div class="wrapper">
      <div class="slider">
              <div class="item">
                <a href="#pone-0000761-g001" data-doi="info:doi/10.1371/journal.pone.0000761" data-uri="info:doi/10.1371/journal.pone.0000761.g001" title="Figure 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000761.g001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000761-g002" data-doi="info:doi/10.1371/journal.pone.0000761" data-uri="info:doi/10.1371/journal.pone.0000761.g002" title="Figure 2">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000761.g002&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000761-g003" data-doi="info:doi/10.1371/journal.pone.0000761" data-uri="info:doi/10.1371/journal.pone.0000761.g003" title="Figure 3">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000761.g003&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000761-g004" data-doi="info:doi/10.1371/journal.pone.0000761" data-uri="info:doi/10.1371/journal.pone.0000761.g004" title="Figure 4">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000761.g004&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000761-g005" data-doi="info:doi/10.1371/journal.pone.0000761" data-uri="info:doi/10.1371/journal.pone.0000761.g005" title="Figure 5">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000761.g005&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
      </div>
    </div>
  </div>

  <div class="nav-col">
    <div class="nav" id="nav-article-page">
      <ul>
        <li class="nav-col-comments"><a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0000761">Reader Comments (0)</a></li>
          <li id="nav-figures"><a data-doi="info:doi/10.1371/journal.pone.0000761" >Figures</a></li>
      </ul>
    </div>
  </div>

  <div class="article">







<div class="abstract"><a id="abstract0" name="abstract0" toc="abstract0" title="Abstract"></a><h2>Abstract</h2><a id="article1.front1.article-meta1.abstract1.p1" name="article1.front1.article-meta1.abstract1.p1"></a><p>Optimization of a serotype-selective, small-molecule inhibitor of botulinum neurotoxin serotype A (BoNTA) endopeptidase is a formidable challenge because the enzyme-substrate interface is unusually large and the endopeptidase itself is a large, zinc-binding protein with a complex fold that is difficult to simulate computationally. We conducted multiple molecular dynamics simulations of the endopeptidase in complex with a previously described inhibitor (<em>K</em><sub>i</sub><sup>app</sup> of 7±2.4 µM) using the cationic dummy atom approach. Based on our computational results, we hypothesized that introducing a hydroxyl group to the inhibitor could improve its potency. Synthesis and testing of the hydroxyl-containing analog as a BoNTA endopeptidase inhibitor showed a twofold improvement in inhibitory potency (<em>K</em><sub>i</sub><sup>app</sup> of 3.8±0.8 µM) with a relatively small increase in molecular weight (16 Da). The results offer an improved template for further optimization of BoNTA endopeptidase inhibitors and demonstrate the effectiveness of the cationic dummy atom approach in the design and optimization of zinc protease inhibitors.</p>
</div>


<div class="articleinfo"><p><strong>Citation: </strong>Tang J, Park JG, Millard CB, Schmidt JJ, Pang Y-P (2007) Computer-Aided Lead Optimization: Improved Small-Molecule Inhibitor of the Zinc Endopeptidase of Botulinum Neurotoxin Serotype A. PLoS ONE 2(8):
          e761.
            doi:10.1371/journal.pone.0000761</p><p><strong>Academic Editor: </strong>Hany El-Shemy, Cairo University, Egypt</p><p><strong>Received:</strong> April 17, 2007; <strong>Accepted:</strong> July 16, 2007; <strong>Published:</strong> August 22, 2007</p><p>This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.</p><p><strong>Funding: </strong>Supported by Advanced Research Projects Agency (DAAD19-01-1-0322), the U.S. Army Medical Research Acquisition Activity (W81XWH-04-2-0001), and the National Institutes of Health/National Institute of Allergy and Infectious Diseases (5R01AI054574-03).</p><p><strong>Competing interests:</strong> TJ, JGP, CBM, JJS and YPP have filed a PCT application for the inhibitors described in this paper.</p></div>





<div id="section1" class="section"><a id="s1" name="s1" toc="s1" title="Introduction"></a><h3>Introduction</h3><a id="article1.body1.sec1.p1" name="article1.body1.sec1.p1"></a><p>Botulinum neurotoxin serotype A (BoNTA) is a protein produced by the spore-forming anaerobic bacterium, <em>Clostridium botulinum</em>. The neurotoxin consists of a light chain (M<sub>r</sub> ~50,000) and a heavy chain (M<sub>r</sub>~100,000) linked covalently by a disulfide bond. BoNTA poisoning selectively inhibits the release of acetylcholine from presynaptic nerve terminals at neuromuscular junctions, thus causing flaccid paralysis and leading to prolonged mechanical ventilation with serious medical sequelae or death following respiratory arrest <a href="#pone.0000761-Shapiro1">[1]</a>. In small doses BoNTA is an effective medical treatment for a variety of cholinergic nerve and muscle dysfunctions <a href="#pone.0000761-Kessler1">[2]</a>, <a href="#pone.0000761-Springen1">[3]</a>. In addition to its medical applications, BoNTA has gained notoriety as a bioterror agent <a href="#pone.0000761-Singh1">[4]</a>. Because there is no antidote to BoNTA, effective small-molecule inhibitors of BoNTA are highly sought after as antidotes and as potential medical tools for modulating clinical uses of the toxin.</p>
<a id="article1.body1.sec1.p2" name="article1.body1.sec1.p2"></a><p>The light-chain domain of BoNTA is a zinc endopeptidase that specifically cleaves SNAP-25, a neuronal protein required for acetylcholine release <a href="#pone.0000761-Simpson1">[5]</a>. The endopeptidase has been used as a target for developing small-molecule inhibitors of BoNTA <a href="#pone.0000761-Burnett1">[6]</a>–<a href="#pone.0000761-Burnett2">[15]</a>. Recently, we reported the development of a serotype-selective, small-molecule inhibitor of BoNTA with a <em>K</em><sub>i </sub>of 12±2.6 µM (<strong>1</strong>, <a href="#pone-0000761-g001">Figure 1</a>) <a href="#pone.0000761-Park1">[7]</a>. Developing or optimizing small-molecule inhibitors of BoNTA endopeptidase is, however, as challenging as developing small-molecule inhibitors of protein-protein complexes, a challenge that has been known for decades <a href="#pone.0000761-Arkin1">[16]</a>. The challenge in the case of BoNTA endopeptidase inhibitors can be partly attributed to the substrate that wraps around the circumference of BoNTA endopeptidase upon binding and creates a substrate-enzyme interface of 4840 Å<sup>2</sup> <a href="#pone.0000761-Breidenbach1">[17]</a>. This large interface requires a high-affinity small molecule to block it. The extent of this challenge can be appreciated by comparing the interface area of BoNTA endopeptidase (4840 Å<sup>2</sup>) to the typical protein-protein interface area of 750–1500 Å<sup>2</sup> <a href="#pone.0000761-Arkin1">[16]</a>. Another part of the challenge in developing and optimizing these inhibitors is the endopeptidase itself, which is a large zinc-binding protein with a complex fold that is capable of large-scale conformational changes in solution and that is therefore difficult to simulate computationally <a href="#pone.0000761-Breidenbach1">[17]</a>. Consequently, computer-aided optimization of BoNTA endopeptidase inhibitor leads has not been reported until now.</p>
<div class="figure" id="pone-0000761-g001"><div class="img"><a name="pone-0000761-g001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000761.g001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000761" data-uri="info:doi/10.1371/journal.pone.0000761.g001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000761.g001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000761.g001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000761.g001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000761.g001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000761.g001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000761.g001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000761.g001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000761.g001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000761.g001.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 1.  <span>Chemical structures of inhibitors 1 and 2.</span></strong></p><span>doi:10.1371/journal.pone.0000761.g001</span></div><a id="article1.body1.sec1.p3" name="article1.body1.sec1.p3"></a><p>We report computer-aided optimization of <strong>1</strong> to arrive at an improved, serotype-selective, small-molecule BoNTA endopeptidase inhibitor with an “apparent” <em>K</em><sub>i</sub> (<em>K</em><sub>i</sub><sup>app</sup>) of 3.8±0.8 µM. This optimization was guided by multiple molecular dynamics simulations (MMDSs) of the zinc-containing endopeptidase in complex with <strong>1</strong> using the cationic dummy atom (CaDA) approach. This approach introduces four identical dummy atoms in a tetrahedral geometry around the zinc ion and transfers all the atomic charge of the zinc divalent cation evenly to the dummy atoms. The four peripheral atoms are “dummy” in that they interact with other atoms electrostatically but not sterically, thus mimicking the <em>4s4p<sup>3</sup></em> vacant orbitals of the zinc divalent cation that accommodate the lone-pair electrons of zinc coordinates <a href="#pone.0000761-Roe1">[18]</a>–<a href="#pone.0000761-Oelschlaeger2">[23]</a>. The results offer an improved template for further optimization of BoNTA endopeptidase inhibitors and demonstrate that the CaDA approach is useful for both design and optimization of zinc protease inhibitors.</p>
</div>

<div id="section2" class="section"><a id="s2" name="s2" toc="s2" title="Results"></a><h3>Results</h3>
<h4>Design</h4>
<a id="article1.body1.sec2.sec1.p1" name="article1.body1.sec2.sec1.p1"></a><p>Inhibitor <strong>1</strong> was designed to coordinate the zinc divalent cation embedded in the active site of BoNTA endopeptidase for affinity and simultaneously to interact with serotype-specific residues in the active site for selectivity <a href="#pone.0000761-Park1">[7]</a>. This design was based on previous MMDSs using the CaDA approach. The MMDSs (20 simulations) of the endopeptidase in complex with <strong>1</strong> showed that (1) the hydroxamate group coordinated the active-site zinc ion; (2) the phenyl group substituted at the thiophene ring had a π-π interaction with Phe193 and a cation-π interaction with Arg362; (3) the indole ring was engaged in a cation-π interaction with Lys165; (4) the phenyl group attached to the indole ring had a van der Waals interaction with the side chain of Leu527 and a cation-π interaction with Lys165; (5) the ammonium group interacted with the carboxylates of Glu54 and Glu55 <a href="#pone.0000761-Park1">[7]</a>. The absolute free energy binding between <strong>1</strong> and the endopeptidase was estimated to be −7.5 kcal/mol according to a free energy perturbation calculation of the MMDS-derived model of the <strong>1</strong>-bound endopeptidase using a published method <a href="#pone.0000761-Pang4">[24]</a> with modifications described in <a href="#s4">MATERIALS AND METHODS</a>. These computational observations were consistent with the experimentally determined <em>K</em><sub>i</sub><sup>app</sup> of 7±2.4 µM (ΔG ranging from –6.9 to –7.3 kcal/mol) for <strong>1</strong> (see below). In this context, the MMDS-derived model of the <strong>1</strong>-bound endopeptidase was used for the following lead optimization.</p>
<a id="article1.body1.sec2.sec1.p2" name="article1.body1.sec2.sec1.p2"></a><p>An analysis of the MMDS trajectories of the endopeptidase in complex with <strong>1</strong> identified a vacancy around the <em>meta</em> position of the phenyl group substituted on the thiophene of <strong>1</strong>. Synthetically, this void can be filled by a hydroxyl group substituted at the phenyl ring. This hydroxyl group can form hydrogen bonds with active-side residues to improve the affinity for the endopeptidase and the introduction of this hydroxyl group can also increase the hydrophilicity of <strong>1</strong> because dimethyl sulfoxide is needed to dissolve <strong>1</strong> in water. These considerations led to the design of inhibitor <strong>2</strong> (<a href="#pone-0000761-g001">Figure 1</a>). MMDSs (20 simulations) of the endopeptidase in complex with <strong>2</strong> were carried out to confirm the anticipated hydrogen bonds. The result of these simulations suggested that <strong>2</strong> binds at the active site of BoNTA endopeptidase in a manner similar to that of <strong>1</strong> and that the hydroxyl group attached to the phenyl group of <strong>2</strong> indeed has hydrogen bonds with Arg362 and Asp369 of the endopeptidase (<a href="#pone-0000761-g002">Figure 2</a>). In the average structure of the endopeptidase complex obtained from 10,000 instantaneous structures at 1.0-ps intervals during the last 0.5-ns period of the 20 different simulations using an explicit water model <a href="#pone.0000761-Jorgensen1">[25]</a>, the hydrogen bond of <strong>2</strong> to Arg362 is bridged by a water molecule; the average distances from the phenolic oxygen atom to the carboxylate oxygen atom of Asp369 and the water oxygen atom are 2.9 Å and 2.3 Å, respectively; the average distance between the water oxygen atom and the closest guanidinium nitrogen atom of Arg362 is 3.3 Å.</p>
<div class="figure" id="pone-0000761-g002"><div class="img"><a name="pone-0000761-g002" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000761.g002&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000761" data-uri="info:doi/10.1371/journal.pone.0000761.g002"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000761.g002&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000761.g002/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000761.g002/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000761.g002/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000761.g002/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000761.g002.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000761.g002/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000761.g002/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000761.g002.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 2.  <span>A close-up view of inhibitor 2 binding at the active site of the botulinum neurotoxin serotype A endopeptidase.</span></strong></p><a id="article1.body1.sec2.sec1.fig1.caption1.p1" name="article1.body1.sec2.sec1.fig1.caption1.p1"></a><p>The 3D model was generated by averaging 10,000 instantaneous structures obtained at 1.0-ps intervals during the last 0.5-ns period of 20 molecular dynamics simulations (2.0 ns for each simulation with a 1.0-fs time step and a unique seed for initial velocities) followed by 200 steps of energy minimization of the average structure of the entire complex.</p>
<span>doi:10.1371/journal.pone.0000761.g002</span></div>

<h4>Synthesis</h4>
<a id="article1.body1.sec2.sec2.p1" name="article1.body1.sec2.sec2.p1"></a><p>The initial synthesis of <strong>2</strong> followed a published scheme <a href="#pone.0000761-Park1">[7]</a> that was devised to synthesize <strong>1</strong>. The starting material methyl 2-(2-(3-hydroxyphenyl)thiophen-3-yl)acet​ate(<strong>4</strong>) was prepared using Suzuki coupling <a href="#pone.0000761-Miyaura1">[26]</a>–<a href="#pone.0000761-Miyaura2">[28]</a> (<a href="#pone-0000761-g003">Figure 3</a>). However, the yield of Friedel-Crafts acylation <a href="#pone.0000761-Joule1">[29]</a>, <a href="#pone.0000761-Gupta1">[30]</a> for preparing <strong>5</strong> (<a href="#pone-0000761-g003">Figure 3</a>) was reduced to 10%, presumably owing to the hydroxyl group substituted at the phenyl ring. To increase the yield, a new scheme was devised to perform Friedel-Crafts acylation first and then Suzuki coupling (<a href="#pone-0000761-g004">Figure 4</a>); this scheme enables facile derivatization of the phenyl group substituted at the thiophene ring via a traditional or combinatorial chemistry approach. As shown in <a href="#pone-0000761-g004">Figure 4</a>, Heck alkynylation <a href="#pone.0000761-Dieck1">[31]</a> of <strong>7</strong>, which carries both bromo and iodo atoms, was selectively achieved to afford <strong>8</strong> by using PhCCH/Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, and Et<sub>3</sub>N in DMF. A catalytic amount of InBr<sub>3</sub> <a href="#pone.0000761-Sakai1">[32]</a> was used for the indole formation to obtain <strong>9</strong> in a high yield. To obtain <strong>10</strong>, <em>N</em>-alkylation of the indole ring was carried out under the same conditions reported for the synthesis of <strong>1</strong> <a href="#pone.0000761-Park1">[7]</a>. Refluxing <strong>10</strong> with 3-hydroxyphenylboronic acid in toluene:ethanol containing PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> and Na<sub>2</sub>CO<sub>3</sub> gave <strong>11</strong> in a higher yield than a known procedure <a href="#pone.0000761-Meegalla1">[33]</a>. The final product <strong>2</strong> was obtained by a reaction of <strong>11</strong> with excess hydroxylamine <a href="#pone.0000761-Ho1">[34]</a> that simultaneously converted methyl ester and phthalimide to hydroxamic acid and amine, respectively <a href="#pone.0000761-Mootoo1">[35]</a>, <a href="#pone.0000761-Ariffin1">[36]</a>. High-performance liquid chromatography (HPLC) purification using solvent containing trifluoroacetic acid yielded pure <strong>2</strong> in its trifluoroacetic acid salt form that was used for the following testing.</p>
<div class="figure" id="pone-0000761-g003"><div class="img"><a name="pone-0000761-g003" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000761.g003&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000761" data-uri="info:doi/10.1371/journal.pone.0000761.g003"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000761.g003&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000761.g003/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000761.g003/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000761.g003/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000761.g003/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000761.g003.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000761.g003/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000761.g003/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000761.g003.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 3.  <span>Synthetic scheme for intermediate 5.</span></strong></p><span>doi:10.1371/journal.pone.0000761.g003</span></div><div class="figure" id="pone-0000761-g004"><div class="img"><a name="pone-0000761-g004" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000761.g004&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000761" data-uri="info:doi/10.1371/journal.pone.0000761.g004"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000761.g004&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000761.g004/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000761.g004/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000761.g004/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000761.g004/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000761.g004.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000761.g004/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000761.g004/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000761.g004.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 4.  <span>Synthetic scheme for inhibitor 2.</span></strong></p><span>doi:10.1371/journal.pone.0000761.g004</span></div>

<h4>Testing</h4>
<a id="article1.body1.sec2.sec3.p1" name="article1.body1.sec2.sec3.p1"></a><p>HPLC-based kinetics assays <a href="#pone.0000761-Schmidt1">[37]</a> were used to measure the inhibition of BoNTA endopeptidase and a related endopeptidase from botulinum neurotoxin serotype B by <strong>1</strong> and <strong>2</strong>. A <em>K</em><sub>i</sub> value of 12±2.6 µM was previously obtained for <strong>1</strong> that was assumed to be a competitive inhibitor <a href="#pone.0000761-Park1">[7]</a>. A further investigation on inhibitor effectiveness in this study revealed nonlinear Dixon plots for both <strong>1</strong> and <strong>2</strong> with data obtained at the condition of [S]&lt;&lt;<em>K</em><sub>M</sub> (<a href="#pone-0000761-g005">Figure 5</a>). The curvature of these plots indicates a partially competitive inhibition mechanism for <strong>1</strong> and <strong>2</strong> <a href="#pone.0000761-Todhunter1">[38]</a>; it precludes determination of <em>K</em><sub>i</sub> values using standard kinetic methods and invalidates the previously reported <em>K</em><sub>i</sub> value for <strong>1</strong>. To compare the relative inhibitory potencies of the two inhibitors, <em>K</em><sub>i</sub><sup>app</sup> values of <strong>1</strong> and <strong>2</strong> were therefore obtained from the slope of 1/ν versus [I] at the conditions of [S]&lt;&lt;<em>K</em><sub>M</sub> and inhibitor concentrations less than 15.0 µM and 5.4 µM, respectively, according to a literature procedure <a href="#pone.0000761-Todhunter1">[38]</a>, <a href="#pone.0000761-Shapiro2">[39]</a>. The Dixon plots for <strong>1</strong> and <strong>2</strong> are approximately linear at relatively low concentrations (<a href="#pone-0000761-g005">Figure 5</a>). Consequently, the kinetics assays showed that (1) at low inhibitor concentrations, <strong>1</strong> and <strong>2</strong> are competitive inhibitors of BoNTA endopeptidase with <em>K</em><sub>i</sub><sup>app</sup> values of 7±2.4 µM and 3.8±0.8 µM, respectively, in HEPES buffer at pH 7.3, consistent with the half maximal inhibitory concentrations independently determined for the inhibition of BoNTA endopeptidase by <strong>1</strong> (15±1.5 µM) and <strong>2 (</strong>7.9±0.8 µM); (2) the <em>K</em><sub>i</sub><sup>app</sup> values of <strong>1</strong> and <strong>2</strong> were unaffected after the zinc concentration of the assay was increased from 25 µM to 50 µM while holding all other experimental variables constant; (3) <strong>1</strong> and <strong>2</strong> did not inhibit botulinum neurotoxin serotype B endopeptidase at concentrations up to 20 µM (data not shown). These results preclude the possibility that the inhibition of BoNTA endopeptidase by <strong>1</strong> or <strong>2</strong> was due to nonspecific zinc chelation. All the observations demonstrate that <strong>2</strong> is a more potent BoNTA endopeptidase inhibitor than <strong>1</strong>.</p>
<div class="figure" id="pone-0000761-g005"><div class="img"><a name="pone-0000761-g005" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000761.g005&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000761" data-uri="info:doi/10.1371/journal.pone.0000761.g005"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000761.g005&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000761.g005/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000761.g005/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000761.g005/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000761.g005/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000761.g005.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000761.g005/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000761.g005/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000761.g005.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 5.  <span>Dixon plots for inhibition of the botulinum neurotoxin serotype A endopeptidase by inhibitors 1 (upper panels) and 2 (lower panels).</span></strong></p><a id="article1.body1.sec2.sec3.fig1.caption1.p1" name="article1.body1.sec2.sec3.fig1.caption1.p1"></a><p>The right panels are the scale-up of the left panels.</p>
<span>doi:10.1371/journal.pone.0000761.g005</span></div>
</div>

<div id="section3" class="section"><a id="s3" name="s3" toc="s3" title="Discussion"></a><h3>Discussion</h3>
<h4>Improved Inhibitor of BoNTA Endopeptidase</h4>
<a id="article1.body1.sec3.sec1.p1" name="article1.body1.sec3.sec1.p1"></a><p>Our results show that <strong>1</strong> and <strong>2</strong> are competitive inhibitors of BoNTA endopeptidase at inhibitor concentrations less than 15.0 µM and 5.4 µM, respectively, and that the <em>K</em><sub>i</sub><sup>app</sup> values of <strong>1</strong> and <strong>2</strong> are 7±2.4 µM and 3.8±0.8 µM, respectively. However, both inhibitors are partially competitive inhibitors at relatively high inhibitor concentrations. These observations are not unprecedented. It has been reported that a Dixon plot of a dipeptide inhibitor (Gly-Trp) of angiotensin converting enzyme showed a competitive inhibition mechanism at relatively low inhibitor concentrations and a complex inhibition mechanism at relatively high concentrations, whereas the same inhibitor showed a competitive inhibition mechanism in a Lineweaver-Burk plot <a href="#pone.0000761-Shapiro2">[39]</a>. Interestingly, both BoNTA endopeptidase and angiotensin converting enzyme are zinc-bound enzymes. Further studies are needed to investigate the detailed inhibition mechanisms of <strong>1</strong> and <strong>2</strong> at relatively high concentrations. Nevertheless, the results of this study show clearly that <strong>2</strong> is a more potent BoNTA endopeptidase inhibitor than <strong>1</strong>, as evident from the Dixon plots shown in <a href="#pone-0000761-g005">Figure 5</a> and from the half maximal inhibitory concentrations determined for the inhibition of BoNTA endopeptidase by <strong>1</strong> (15±1.5 µM) and <strong>2</strong> (7.9±0.8 µM).</p>


<h4>Efficiency of computer-aided optimization</h4>
<a id="article1.body1.sec3.sec2.p1" name="article1.body1.sec3.sec2.p1"></a><p>While the optimization of <strong>1</strong> reported here was guided by MMDSs using the CaDA approach, 12 other analogs of <strong>1</strong> were made according to the scheme shown in <a href="#pone-0000761-g004">Figure 4</a> using commercially available phenylboronic acids without the MMDSs guidance. Interestingly, none of these brute-force-approach-based derivatives was found to be more potent than <strong>2</strong> (data not shown). In terms of lead optimization for <em>in vitro</em> potency, which is an important step in drug development, the present work offers another demonstration of the relative efficiency of using computer simulations instead of the brute force approach for lead optimization. The results suggest that the CaDA approach is useful for both design and optimization of zinc protease inhibitors.</p>


<h4>Strategy for endopeptidase inhibitor optimization</h4>
<a id="article1.body1.sec3.sec3.p1" name="article1.body1.sec3.sec3.p1"></a><p>As described above, the interface between BoNTA endopeptidase and its substrate is more than twice as large as typical protein-protein interfaces <a href="#pone.0000761-Arkin1">[16]</a>, <a href="#pone.0000761-Breidenbach1">[17]</a>. This large interface causes a conflict in the design and optimization of medically useful BoNTA endopeptidase inhibitors in that, on the one hand, a large molecule is needed to gain more interactions at the unusually large interface, and on the other hand, a small molecule is required to ensure good cell permeability. To avoid the conflict, optimization should be directed towards improving inhibitor affinity with a small increase in molecular weight. This strategy is necessary in early stages of optimization of a micromolar lead because a bivalence or fragment-based approach will be used in later stages of the optimization to take advantage of peripheral sites or exosites on the endopeptidase to achieve high affinity <a href="#pone.0000761-Merino1">[12]</a>, <a href="#pone.0000761-Johnson1">[13]</a>, <a href="#pone.0000761-Breidenbach1">[17]</a>, <a href="#pone.0000761-Pang5">[40]</a>, <a href="#pone.0000761-Pang6">[41]</a>. The bivalence or fragment-based approach will be inapplicable to the optimization if the molecular weight of a lead is already too high. At present, the molecular weights of <strong>1</strong> and <strong>2</strong> are 524 and 540 Da, respectively. This study shows that it is practical to achieve a twofold improvement in inhibitory potency with a molecular weight increase of only 16 Da by adding one oxygen atom, given the guidance of the MMDSs of BoNTA endopeptidase using the CaDA approach. Further optimization of <strong>2</strong> following the example reported herein is underway and will be reported in due course.</p>

</div>

<div id="section4" class="section"><a id="s4" name="s4" toc="s4" title="Materials and Methods"></a><h3>Materials and Methods</h3>
<h4>Computational Methods</h4>
<h5>Preparation of the zinc- and inhibitor-bound endopeptidase.</h5><a id="article1.body1.sec4.sec1.sec1.p1" name="article1.body1.sec4.sec1.sec1.p1"></a><p>The initial structure of the zinc-containing BoNTA endopeptidase was taken from an available crystal structure of a BoNTA endopeptidase mutant (Glu224Gln and Tyr366Phe; Protein Data Bank code: 1XTG, residue numbers of 1XTG described in this section deviate by one from the residue numbers described in RESULTS and in <a href="#pone-0000761-g002">Figure 2</a>) <a href="#pone.0000761-Breidenbach1">[17]</a>. To change the mutant back to the wildtype, residues 224 and 366 were mutated to Glu and Tyr, respectively, and the dihedral N-CA-CB-CG of Tyr366 was changed from 65.66 to –171.84° of arc. Hydrogen atoms of the endopeptidase were added by using the QUANTA97 program (Accelrys Software, Inc, San Diego, California). The zinc divalent cation in the crystal structure was replaced by the tetrahedron-shaped zinc divalent cation that has four cationic dummy atoms surrounding the central zinc ion <a href="#pone.0000761-Pang1">[19]</a> (for more information on zinc protein simulations see “<a href="http://mayoresearch.mayo.edu/mayo/research/camdl/zinc_protein.cfm">http://mayoresearch.mayo.edu/mayo/resear​ch/camdl/zinc_protein.cfm</a>”). His223, His227, and Glu262, which are the first-shell zinc coordinates, were treated as histidinate (HIN) and glutamate (GLU), respectively <a href="#pone.0000761-Pang1">[19]</a>, <a href="#pone.0000761-Pang2">[20]</a>, <a href="#pone.0000761-ElYazal1">[42]</a>–<a href="#pone.0000761-ElYazal3">[44]</a>. Glu261 and Glu351, which form a hydrogen bond with His223 and His227 respectively, were treated as glutamic acid (GLH) <a href="#pone.0000761-Pang1">[19]</a>, <a href="#pone.0000761-Pang2">[20]</a>, <a href="#pone.0000761-ElYazal1">[42]</a>–<a href="#pone.0000761-ElYazal3">[44]</a>. His170 and His269 were treated as the histidine whose epsilon nitrogen atom is protonated (HIE); His39 and His230 were treated as the histidine whose delta nitrogen atom is protonated (HID) and histidinium (HIP), respectively. Inhibitor <strong>1</strong> or <strong>2</strong> was manually docked into the active site of the endopeptidase according to a previously reported 3D model of inhibitor <strong>1</strong>-bound BoNTA endopeptidase <a href="#pone.0000761-Park1">[7]</a>. One chloride ion was added next to the ammonium group of Lys381 located on the surface of the protein to neutralize the protein. The published force field parameters of the tetrahedron-shaped zinc divalent cation <a href="#pone.0000761-Park1">[7]</a> were used in energy minimizations and in the following described molecular dynamics simulations. The RESP charges and the AMBER force field parameters of inhibitors <strong>1</strong> and <strong>2</strong> were generated by using the ANTECHAMBER module of the AMBER 7 program <a href="#pone.0000761-Pearlman1">[45]</a> and the structures of <strong>1</strong> and <strong>2</strong> that were optimized at the HF/6-31G* level with the Gaussian 98 Program <a href="#pone.0000761-Frisch1">[46]</a> (<a href="#pone.0000761.s003">Figure S1</a> and <a href="#pone.0000761.s001">Tables S1</a> and <a href="#pone.0000761.s002">S2</a>). A 10,000-step energy minimization was first performed on inhibitor <strong>2</strong> with a positional constraint applied to the rest of the complex. A 50-step energy minimization was then performed on the tetrahedron-shaped zinc divalent cation and <strong>2</strong> with a positional constraint applied to the endopeptidase only. A 200-step energy minimization was lastly performed on the entire complex without any constraint.</p>

<h5>Multiple molecular dynamics simulations.</h5><a id="article1.body1.sec4.sec1.sec2.p1" name="article1.body1.sec4.sec1.sec2.p1"></a><p>All MMDSs (2.0 ns for each simulation with a unique seed number for starting velocities of the system) were performed according to a published protocol <a href="#pone.0000761-Pang7">[47]</a> using the PMEMD module of the AMBER 8 program <a href="#pone.0000761-Pearlman1">[45]</a> with the Cornell et al. force field (parm99.dat) <a href="#pone.0000761-Cornell1">[48]</a>. The topology and coordinate files used for the MMDSs were generated by the PREP, LINK, EDIT, and PARM modules of the AMBER 5 program <a href="#pone.0000761-Pearlman1">[45]</a>. All simulations used (1) a dielectric constant of 1.0; (2) the Berendsen coupling algorithm <a href="#pone.0000761-Berendsen1">[49]</a>; (3) a periodic boundary condition at a constant temperature of 300 K and a constant pressure of 1 atm with isotropic molecule-based scaling; (4) the Particle Mesh Ewald method to calculate long-range electrostatic interactions <a href="#pone.0000761-Darden1">[50]</a>; (5) iwrap = 1; (6) a time step of 1.0 fs; (7) the SHAKE-bond-length constraints applied to all the bonds involving the H atom; (8) default values of all other inputs of the PMEMD module. The initial structure of the <strong>2</strong>-bound BoNTA endopeptidase used for the MMDSs had no structural water molecules, and was solvated with TIP3P water molecules <a href="#pone.0000761-Jorgensen1">[25]</a> (EDIT input: NCUBE = 10, QH = 0.4170, DISO = 2.20, DISH = 2.00, CUTX = 8.0, CUTY = 8.0, and CUTZ = 8.0). The solvated endopeptidase complex system was first energy-minimized for 200 steps to remove close van der Waals contacts in the solvated system, slowly heated to 300 K (10 K/ps), and then equilibrated for 1.5 ns. The CARNAL module was used for geometric analysis and for obtaining the time-average structure. All MMDSs were performed on 40 Apple G5 processors. The energy minimization of the time-average structure used “NCYC = 50” and other default inputs of the SANDER module of AMBER 5 <a href="#pone.0000761-Pearlman1">[45]</a>, respectively.</p>

<h5>Free energy perturbation calculation <a href="#pone.0000761-Pang4">[24]</a>.</h5><a id="article1.body1.sec4.sec1.sec3.p1" name="article1.body1.sec4.sec1.sec3.p1"></a><p>The absolute free energy of binding between <strong>1</strong> and BoNTA endopeptidase was obtained by perturbing <strong>1</strong> to nothing over 24 windows of perturbation using the thermodynamics integration method implemented in the SANDER module of AMBER 8 <a href="#pone.0000761-Pearlman1">[45]</a>. Each window was equilibrated and sampled with MMDSs (10 simulations) using the procedure described above. Each of the MMDSs used a 1.0-fs time step and lasted 0.5 ns and 1.0 ns for equilibration and sampling, respectively. The perturbation used 12/24-point Gaussian quadrature and the mixing rule shown in Equation 1. This exceptionally computing intensive calculation was performed on 480 Apple G5 processors for two months.<a name="" id=""></a><span class="equation"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000761.e001&amp;representation=PNG" class="inline-graphic"><span class="note">(Eq.1)</span></span><br></p>



<h4>Experimental Methods</h4>
<h5>Synthesis.</h5><a id="article1.body1.sec4.sec2.sec1.p1" name="article1.body1.sec4.sec2.sec1.p1"></a><p>The<sup> 1</sup>H and <sup>13</sup>C NMR spectra were recorded on a Varian Mercury 400 spectrometer. Chemical shifts are reported in ppm using the solvent resonance as the internal standard. Data are reported as follows: chemical shift, multiplicity (s = single, d = doublet, t = triplet, q = quartet, br = broad, and m = multiplet), integration, and coupling constants. High-resolution mass spectra were obtained on a Bruker BioTOF II ESI. THF and CH<sub>2</sub>Cl<sub>2</sub> were dried using activated alumina columns from Solv-Tek (Berryville, VA). DMF and CH<sub>3</sub>CN were dried by distillation from CaH<sub>2</sub> under N<sub>2</sub>. All other commercially obtained reagents were used as received. Medium-pressure liquid chromatography (MPLC) was performed with Biotage SP-1 (Charlottesville, VA) using silica gel 60 (EM Science, 230-400 mesh).</p>

<h5>Methyl 2-(2-bromo-5-(4-iodo-3-nitrobenzoyl)thio​phen-3-yl)acetate(7).</h5><a id="article1.body1.sec4.sec2.sec2.p1" name="article1.body1.sec4.sec2.sec2.p1"></a><p>To a stirred solution of 2-(thiophen-3-yl)acetic acid (<strong>6</strong>, 28.00 g, 196.94 mmol) in methanol (300 mL) was added 12 N HCl (15 mL) and then refluxed for two hours. Methanol was removed by evaporation in vacuo, the residue was dissolved in dichloromethane, washed with saturated NaHCO<sub>3</sub> solution, dried over MgSO<sub>4</sub>, filtered, and concentrated. Kugelrohr distillation of the crude product at 90°C per 0.1 mmHg gave the desired ester as a colorless oil (28.43 g, 92%).</p>
<a id="article1.body1.sec4.sec2.sec2.p2" name="article1.body1.sec4.sec2.sec2.p2"></a><p><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.67 (s, 2H), 3.71 (s, 3H), 7.04 (dd, 1H, <em>J</em> = 1.2, 4.9 Hz), 7.20 (m, 1H), 7.29 (1H, dd, <em>J</em> = 2.0, 4.9 Hz).</p>
<a id="article1.body1.sec4.sec2.sec2.p3" name="article1.body1.sec4.sec2.sec2.p3"></a><p>To a solution of the above ester (10.00 g, 64.02 mmol) in THF (100 mL) was added NBS (11.40 g, 64.02 mmol). The resulting mixture was refluxed for two and a half hours. The solvent was removed in vacuo. MPLC purification (Hex:EtOAc/9:1) of the residue gave (2-bromothiophen-3-yl)acetic acid as a colorless oil (14.55 g, 97%).</p>
<a id="article1.body1.sec4.sec2.sec2.p4" name="article1.body1.sec4.sec2.sec2.p4"></a><p><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.64 (s, 2H), 3.72 (s, 3H), 6.93 (d, 1H, <em>J</em> = 5.6 Hz), 7.25 (d, <em>J</em> = 5.6 Hz).</p>
<a id="article1.body1.sec4.sec2.sec2.p5" name="article1.body1.sec4.sec2.sec2.p5"></a><p>To a stirred solution of methyl (2-bromothiophen-3-yl)acetate (120 mg, 0.51 mmol) and 4-iodo-3-nitrobenzoyl chloride (150 mg, 0.48 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added AlCl<sub>3</sub> (260 mg, 1.95 mmol) in four portions at 10-minute intervals at room temperature. The resulting mixture was stirred overnight. The reaction mixture was slowly poured onto 5 g of ice and allowed to warm to room temperature. The aqueous phase was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×15 mL). The combined organic layer was dried over MgSO<sub>4</sub>, filtered, and then concentrated in vacuo. MPLC purification (Hex:EtOAc/5:1) of the residue gave <strong>7</strong> as a light yellow solid (158 mg, 61%).</p>
<a id="article1.body1.sec4.sec2.sec2.p6" name="article1.body1.sec4.sec2.sec2.p6"></a><p><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.27 (d, 1H, <em>J = </em>2.0 Hz), 8.22 (d, 1H, <em>J = </em>8.0 Hz), 7.70 (dd, 1H, <em>J = </em>2.0, 8.2 Hz), 7.48 (s, 1H), 3.74 (s, 3H) and 3.68 (s, 2H);<sup> 13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 183.8, 170.0, 153.2, 142.9, 141.9, 138.3, 136.5, 135.8, 133.1, 125.7, 124.5, 91.8, 52.6 and 35.0; HRMS-ESI calcd C<sub>14</sub>H<sub>9</sub>BrINO<sub>5</sub>S [M+Na] 531.8322, found 531.8331.</p>

<h5>Methyl 2-(2-bromo-5-(3-nitro-4-(phenylethynyl)b​enzoyl)thiophen-3-yl)acetate(8).</h5><a id="article1.body1.sec4.sec2.sec3.p1" name="article1.body1.sec4.sec2.sec3.p1"></a><p>A solution of <strong>7</strong> (150 mg, 0.29 mmol), phenylacetylene (32 µL, 0.29 mmol), Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2 </sub>(21 mg, 0.03 mmol), K<sub>2</sub>CO<sub>3</sub> (42 mg, 0.29 mmol), and Et<sub>3</sub>N (40 µL, 0.29 mmol) in DMF (3 mL) was stirred for 24 hours at room temperature. Water (5 mL) was added to the mixture and then extracted with EtOAc (3×10 mL). The combined organic layer was washed with brine, dried over MgSO<sub>4</sub>, and concentrated in vacuo. MPLC purification (Hex:EtOAc/5:1) of the residue gave <strong>8</strong> as a solid foam (101 mg, 71 %).</p>
<a id="article1.body1.sec4.sec2.sec3.p2" name="article1.body1.sec4.sec2.sec3.p2"></a><p><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.54 (d, 1H, <em>J = </em>1.6 Hz,); 8.06 (dd, 1H, <em>J = </em>1.6, 8.0 Hz), 7.86 (d, 1H, <em>J = </em>8.4 Hz), 7.64 (m, 2H), 7.52 (s, 1H), 7.42 (m, 3H), 3.75 (s, 3H) and 3.70 (s, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 183.9, 170.1, 149.5, 142.2, 137.0, 136.3, 135.7, 135.3, 132.9, 132.5, 130.1, 128.8, 125.6, 124.3, 122.8, 122.1, 101.1, 84.7, 52.7 and 35.0; HRMS-ESI calcd C<sub>22</sub>H<sub>14</sub>BrNO<sub>5</sub>S [M+Na] 505.9668, found 505.9666.</p>

<h5>Methyl (2-bromo-5-(2-phenyl-1<em>H</em>-indole-6-carbonyl)thiophen-3-yl)acetate (9).</h5><a id="article1.body1.sec4.sec2.sec4.p1" name="article1.body1.sec4.sec2.sec4.p1"></a><p>To a solution of <strong>8</strong> (25 mg, 0.05 mmol) in EtOAc (5 mL) was added stannous chloride dihydrate (58 mg, 0.26 mmol). The resulting mixture was refluxed for one hour under N<sub>2</sub>. The reaction mixture was poured onto ice (5 g), and basified with saturated NaHCO<sub>3</sub> solution to pH 8. The white milky mixture was filtered through a Celite pad to remove tin oxides. The organic layer from the filtrate was dried over MgSO<sub>4</sub>, filtered, and then concentrated in vacuo. MPLC purification (Hex:EtOAc/4:1) of the crude product gave the desired intermediate methyl (2-bromo-5-(3-amino-4-(phenylethynyl)ben​zoyl)thiophen-3-yl)acetateas a yellow foam (21 mg, 90%).</p>
<a id="article1.body1.sec4.sec2.sec4.p2" name="article1.body1.sec4.sec2.sec4.p2"></a><p><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.55 (m, 2H), 7.50 (s, 1H), 7.48 (d, 1H, <em>J</em> = 1.6 Hz), 7.38 (m, 3H), 7.17 (m, 2H), 4.40 (br, 2H), 3.73 (s, 3H) and 3.66 (s, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 186.7, 170.3, 148.1, 143.4, 138.1, 135.9, 135.1, 132.4, 131.8, 129.0, 128.7, 122.9, 122.8, 118.8, 114.5, 112.3, 97.6, 85.3, 52.6 and 35.0; HRMS-ESI calcd C<sub>22</sub>H<sub>16</sub>BrNO<sub>3</sub>S [M+Na] 475.9926, found 475.9923.</p>
<a id="article1.body1.sec4.sec2.sec4.p3" name="article1.body1.sec4.sec2.sec4.p3"></a><p>To a 250 mL flask containing freshly distilled toluene (50 mL) were added methyl (2-bromo-5-(3-amino-4-(phenylethynyl)ben​zoyl)thiophen-3-yl)acetate(2.93 g, 6.45 mmol) and indium tribromide (1.14 g, 3.22 mmol) under N<sub>2</sub>. The resulting mixture was refluxed for one hour. The solvent was removed in vacuo. MPLC purification (Hex:EtOAc/4:1) of the crude product gave <strong>9</strong> as a yellow solid (2.50 g, 85%).</p>
<a id="article1.body1.sec4.sec2.sec4.p4" name="article1.body1.sec4.sec2.sec4.p4"></a><p><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.38 (br, 1H), 7.98 (s, 1H), 7.69 (d, 2H, <em>J</em> = 7.8 Hz), 7.58 (m, 2H), 7.47 (s, 1H), 7.40 (t, 2H, <em>J = </em>7.5 Hz), 7.30 (m, 1 H), 6.80 (s, 1H), 3.65 (s, 3H) and 3.59 (s, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 187.4, 170.5, 144.2, 142.3, 136.5, 135.7, 134.9, 133.3, 131.8, 130.9, 129.4, 128.8, 125.9, 121.9, 120.4, 113.5, 100.3, 52.6 and 35.2; HRMS-ESI calcd C<sub>22</sub>H<sub>16</sub>BrNO<sub>3</sub>S [M+Na] 475.9926, found 475.9945.</p>

<h5>Methyl 2-(2-bromo-5-(1-(4-(1,3-dioxoisoindolin-​2-yl)butyl)-2-phenyl-1<em>H</em>-indole-6-carbonyl)-thiophene-3-yl)aceta​te(10).</h5><a id="article1.body1.sec4.sec2.sec5.p1" name="article1.body1.sec4.sec2.sec5.p1"></a><p>To a stirred solution of <strong>9</strong> (45 mg, 0.10 mmol) in anhydrous CH<sub>3</sub>CN (5 mL) was added CsF-Celite (125 mg) under N<sub>2</sub>, followed by adding <em>N</em>-(4-bromobutyl)-phthalimide (28 mg, 0.10 mmol). The resulting mixture was refluxed for five hours, cooled to room temperature, and filtered. The filtrate was evaporated in vacuo. MPLC purification (Hex:EtOAc/4:1) of the residue gave <strong>10</strong> as a yellow solid (28 mg, 43%).</p>
<a id="article1.body1.sec4.sec2.sec5.p2" name="article1.body1.sec4.sec2.sec5.p2"></a><p><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.98 (s, 1H), 7.74 (m, 6H), 7.59 (s, 1H), 7.47 (m, 5H), 6.60 (s, 1H), 4.32 (t, 2H, <em>J = </em>7.2 Hz), 3.73 (s, 3H), 3.71 (s, 2H), 3.52 (t, 2H, <em>J = </em>6.8 Hz), 1.72 (m, 2H) and 1.51 (m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 187.3, 170.4, 168.5, 145.2, 144.3, 136.8, 135.6, 134.9, 134.2, 134.1, 132.5, 132.1, 130.7, 129.5, 129.0, 128.8, 123.5, 123.4, 121.5, 120.6, 112.5, 103.1, 52.5, 43.7, 37.3, 35.1, 27.4 and 25.8; HRMS-ESI calcd C<sub>34</sub>H<sub>27</sub>BrN<sub>2</sub>O<sub>5</sub>S [M+Na] 677.0716, found 677.0727.</p>

<h5>Methyl 2-(5-(1-(4-(1,3-dioxoisoindolin-2-yl)but​yl)-2-pheny-1<em>H</em>-indole-6-carbonyl-2-(3-<strong>hydroxyphenyl)thiophen-3-yl)acetate (11)</strong>.</h5><a id="article1.body1.sec4.sec2.sec6.p1" name="article1.body1.sec4.sec2.sec6.p1"></a><p>To a solution of 3-hydroxyphenylboronic acid (32 mg, 0.23 mmol) in EtOH (1 mL, degassed with N<sub>2</sub>), was added a solution of <strong>10</strong> (153 mg, 0.23 mmol) in toluene (5 mL), followed by adding Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (16.3 mg, 0.023 mmol) and Na<sub>2</sub>CO<sub>3 </sub>(50 mg, 0.46 mmol). The reaction mixture was refluxed for three hours under N<sub>2</sub>, and then the solvent was removed in vacuo. MPLC purification (Hex:EtOAc/2:1) of the residue gave <strong>11</strong> as a yellow solid (140 mg, 90%).</p>
<a id="article1.body1.sec4.sec2.sec6.p2" name="article1.body1.sec4.sec2.sec6.p2"></a><p><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.98 (s, 1H), 7.70 (m, 2H), 7.64–7.59 (m, 4H), 7.42–7.33 (m, 6H), 7.24 (t, 1H, <em>J = </em>7.9 Hz), 7.07 (t, 1H, <em>J</em> = 2.0 Hz), 6.97 (d, 1H, <em>J</em> = 7.6 Hz), 6.85 (dd, 1H, <em>J</em> = 2.0, 7.9 Hz), 6.52 (s, 1H), 4.23 (t, 2H, <em>J = </em>7.0 Hz), 3.67 (s, 3H), 3.62 (s, 2H), 3.45 (t, 2H, <em>J = </em>6.8 Hz), 1.67 (m, 2H) and 1.42 (m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 188.6, 171.9, 168.8, 157.0, 149.2, 145.2, 141.6, 137.8, 136.7, 134.3, 132.6, 132.1, 131.3, 130.5, 130.4, 129.5, 129.0, 128.8, 123.5, 121.7, 121.3, 120.7, 116.5, 112.8, 103.2, 52.6, 43.7, 37.5, 34.6, 27.5 and 25.9; HRMS-ESI calcd C<sub>40</sub>H<sub>32</sub>N<sub>2</sub>O<sub>6</sub>S [M+Na] 691.1873, found 691.1892.</p>

<h5>2-(5-1-(4-Aminobutyl)-2-phenyl-1<em>H</em>-indole-6-carbonyl)-2-(3-hydroxyphenyl)-​thiophen-3-yl)-<em>N</em>-hydroxyacetamide trifluoroacetic acid salt (2•TFA).</h5><a id="article1.body1.sec4.sec2.sec7.p1" name="article1.body1.sec4.sec2.sec7.p1"></a><p>To a stirred solution of <strong>11</strong> (50 mg, 0.07 mmol) in THF/MeOH (1 mL each), 1 mL of 50% aqueous NH<sub>2</sub>OH was added, followed by adding a catalytic amount of KCN (CAUTION: KCN is highly toxic and must be handled with extreme care by trained personnel). The resulting mixture was stirred overnight at room temperature. After the solvent was removed in vacuo, the residue was washed with water (3×5 mL). HPLC purification of the residue gave <strong>2•TFA</strong> as a yellow powder (32 mg, 65%). HPLC purification condition: Phenomenex Gemini 5 µm, C18, 4.6×250 mm, eluting with linear gradient of 20% of solution A (1000 mL of H<sub>2</sub>O and 45 µL of TFA) to 100% of solution B (100 mL of H<sub>2</sub>O, 900 mL of CH<sub>3</sub>CN, and 45 µL of TFA) over 20 minutes, and flow rate of 1.5 mL/min with a retention time of 12.20 minutes for <strong>2•TFA</strong> (see <a href="#pone.0000761.s004">Figure S2</a> for chromatograms of <strong>2</strong> before and after the HPLC purification).</p>
<a id="article1.body1.sec4.sec2.sec7.p2" name="article1.body1.sec4.sec2.sec7.p2"></a><p><sup>1</sup>H NMR (400 MHz, DMSO-<em>d</em><sub>6</sub>) δ 10.82 (s, 1H), 9.82 (br, 1H), 9.01 (s, 1H), 8.11 (s, 1H), 7.80 (d, 1H, <em>J = </em>2.1 Hz), 7.74 (m, 1H), 7.59–7.50 (m, 6H), 7.30 (m, 1H), 7.04 (d, 1H, <em>J = </em>8.0 Hz), 6.99 (s, 1H), 6.87 (d, 1H, <em>J = </em>8.2 Hz), 6.70 (s, 1H), 4.34 (m, 2H), 3.43 (s, 2H), 2.63 (m, 2H), 1.65 (m, 2H) and 1.31 (m, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<em>d</em><sub>6</sub>) δ 187.7, 167.4, 158.5, 148.2, 145.2, 141.5, 138.4, 136.9, 134.3, 133.0, 132.5, 131.7, 131.2, 130.9, 129.8, 129.6, 129.4, 121.2, 121.0, 120.4, 116.7, 116.4, 113.2, 103.3, 43.8, 39.1, 33.1, 27.4 and 25.0; DEPT-135 <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ 137.6 (CH), 130.9 (CH), 130.1 (CH), 129.3 (CH), 128.8 (CH), 128.7 (CH), 120.7 (CH), 120.6 (CH), 120.3 (CH), 115.9 (CH), 113.0 (CH), 102.9 (CH), 43.4 (CH<sub>2</sub>), 39.2 (CH<sub>2</sub>), 32.3 (CH<sub>2</sub>), 27.1 (CH<sub>2</sub>) and 24.7 (CH<sub>2</sub>); HRMS-ESI calcd C<sub>31</sub>H<sub>29</sub>N<sub>3</sub>O<sub>4</sub>S [M+H] 540.1942, found 540.1934.</p>

<h5>Botulinum neurotoxin inhibition assays.</h5><a id="article1.body1.sec4.sec2.sec8.p1" name="article1.body1.sec4.sec2.sec8.p1"></a><p>Assays of protease activities of BoNTA and botulinum neurotoxin serotype B (BoNTB) were done at 37°C and contained 0.5 mM substrate, 0.5–1.5 µg/mL recombinant BoNTA/BoNTB endopeptidase, 40 mM HEPES, and 0.05% tween at pH 7.3. BoNTA endopeptidase assays also contained 1 mM dithiothreitol, 25 µM ZnCl<sub>2</sub>, and 0.5 mg/mL bovine serum albumin, while BoNTB endopeptidase assays were supplemented with 1 mM dithiothreitol only. Substrate for BoNTA was a peptide containing residues 187–203 of SNAP-25 <a href="#pone.0000761-Schmidt1">[37]</a>, while that for BoNTB was residues 60–94 of VAMP <a href="#pone.0000761-Shone1">[51]</a>. Inhibitors were dissolved in dimethyl sulfoxide at 10 times the final assay concentration, then diluted into the assay mixture containing substrate, followed by addition of endopeptidase (i.e., inhibitor and endopeptidase were not preincubated). Assay times and endopeptidase concentrations were adjusted so that less than 10% of the substrate was hydrolyzed. Assays were stopped by acidification with trifluoroacetic acid and analyzed by reverse-phase HPLC as described <a href="#pone.0000761-Schmidt1">[37]</a>. Inhibition of BoNTA endopeptidase activity by <strong>1</strong> or <strong>2</strong> was determined in three independent experiments using eight and nine concentrations of <strong>1</strong> and <strong>2</strong> in each, respectively.</p>

<h5>Determination of <em>K</em><sub>i</sub><sup>app</sup>.</h5><a id="article1.body1.sec4.sec2.sec9.p1" name="article1.body1.sec4.sec2.sec9.p1"></a><p>For both inhibitors, Dixon plots were nonlinear when the entire range of tested concentrations was included, suggesting a partially competitive inhibition mechanism. Nonetheless, replots of the linear portion of the data, where [S]&lt;&lt;<em>K</em><sub>M</sub> and inhibitor concentrations of <strong>1</strong> and <strong>2</strong> were less than 15.0 µM and 5.4 µM respectively, permitted calculations of <em>K</em><sub>i</sub><sup>app</sup> values for <strong>1</strong> and <strong>2</strong> using the previously established <em>K</em><sub>M</sub> for the substrate measured in the absence of inhibitor <a href="#pone.0000761-Schmidt2">[52]</a> according to a literature procedure <a href="#pone.0000761-Todhunter1">[38]</a>, <a href="#pone.0000761-Shapiro2">[39]</a>.</p>


</div>

<div id="section5" class="section"><a id="s5" name="s5" toc="s5" title="Supporting Information"></a><h3>Supporting Information</h3><div class="figshare_widget" doi="10.1371/journal.pone.0000761"></div><a name="pone.0000761.s001" id="pone.0000761.s001"></a><p class="siTitle"><strong><a href="/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0000761.s001">Table S1. </a></strong></p><a id="article1.body1.sec5.supplementary-material1.caption1.p1" name="article1.body1.sec5.supplementary-material1.caption1.p1"></a><p class="preSiDOI">The AMBER atom types and charges of inhibitors of 1 and 2.</p>
<p class="siDoi">doi:10.1371/journal.pone.0000761.s001</p><a id="article1.body1.sec5.supplementary-material1.caption1.p2" name="article1.body1.sec5.supplementary-material1.caption1.p2"></a><p class="postSiDOI">(0.15 MB DOC)</p>
<a name="pone.0000761.s002" id="pone.0000761.s002"></a><p class="siTitle"><strong><a href="/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0000761.s002">Table S2. </a></strong></p><a id="article1.body1.sec5.supplementary-material2.caption1.p1" name="article1.body1.sec5.supplementary-material2.caption1.p1"></a><p class="preSiDOI">The AMBER force field parameters of inhibitors of 1 and 2.</p>
<p class="siDoi">doi:10.1371/journal.pone.0000761.s002</p><a id="article1.body1.sec5.supplementary-material2.caption1.p2" name="article1.body1.sec5.supplementary-material2.caption1.p2"></a><p class="postSiDOI">(0.12 MB DOC)</p>
<a name="pone.0000761.s003" id="pone.0000761.s003"></a><p class="siTitle"><strong><a href="/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0000761.s003">Figure S1. </a></strong></p><a id="article1.body1.sec5.supplementary-material3.caption1.p1" name="article1.body1.sec5.supplementary-material3.caption1.p1"></a><p class="preSiDOI">Definition of atom names of inhibitors of 1 and 2.</p>
<p class="siDoi">doi:10.1371/journal.pone.0000761.s003</p><a id="article1.body1.sec5.supplementary-material3.caption1.p2" name="article1.body1.sec5.supplementary-material3.caption1.p2"></a><p class="postSiDOI">(9.48 MB TIF)</p>
<a name="pone.0000761.s004" id="pone.0000761.s004"></a><p class="siTitle"><strong><a href="/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0000761.s004">Figure S2. </a></strong></p><a id="article1.body1.sec5.supplementary-material4.caption1.p1" name="article1.body1.sec5.supplementary-material4.caption1.p1"></a><p class="preSiDOI">Chromatograms of inhibitor 2 before and after the HPLC purification.</p>
<p class="siDoi">doi:10.1371/journal.pone.0000761.s004</p><a id="article1.body1.sec5.supplementary-material4.caption1.p2" name="article1.body1.sec5.supplementary-material4.caption1.p2"></a><p class="postSiDOI">(1.33 MB TIF)</p>
</div>





<div><a id="ack" name="ack" toc="ack" title="Acknowledgments"></a><h3>Acknowledgments</h3>
<a id="article1.back1.ack1.p1" name="article1.back1.ack1.p1"></a><p>The authors thank Steve Whiting and Seth Swaii for their assistance in preparing synthetic intermediates <strong>3</strong> and <strong>7–11</strong> and acknowledge the computing support from the Aeronautical Systems Center of the High Performance Computing Modernization Program of the U.S. Department of Defense, and the University of Minnesota Supercomputing Institute.</p>
<a id="article1.back1.ack1.p2" name="article1.back1.ack1.p2"></a><p>Disclaimer: The opinions or assertions contained herein belong to the authors and are not necessarily the official views of the U.S. Army, the U.S. Department of Defense, or the U.S. National Institutes of Health.</p>
</div><div class="contributions"><a id="authcontrib" name="authcontrib" toc="authcontrib" title="Author Contributions"></a><h3>Author Contributions</h3><p>Conceived and designed the experiments: YP JT JP CM JS. Performed the experiments: YP JT JP JS. Analyzed the data: YP JT JP CM JS. Wrote the paper: YP JT JP CM JS.</p></div><div><a id="references" name="references" toc="references" title="References"></a><h3>References</h3><ol class="references"><li><span class="label">1.
              </span><a name="pone.0000761-Shapiro1" id="pone.0000761-Shapiro1"></a>Shapiro RL, Hatheway C, Swerdlow DL (1998) Botulism in the United States-a clinical and epidemiologic review. Ann Intern Med  129: 221–228.  <ul class="find" data-citedArticleID="979584" data-doi="10.7326/0003-4819-129-3-199808010-00011"><li><a href="http://dx.doi.org/10.7326/0003-4819-129-3-199808010-00011" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Botulism+in+the+United+States-a+clinical+and+epidemiologic+review." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Botulism+in+the+United+States-a+clinical+and+epidemiologic+review.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">2.
              </span><a name="pone.0000761-Kessler1" id="pone.0000761-Kessler1"></a>Kessler KR, Benecke R (1997) Botulinum toxin—from poison to remedy. Neurotoxicology  18: 761–770.  <ul class="find" data-citedArticleID="979542"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Botulinum+toxin%26%23x2014%3Bfrom+poison+to+remedy.&amp;auth=&amp;atitle=Botulinum+toxin%26%23x2014%3Bfrom+poison+to+remedy." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Botulinum+toxin%26%23x2014%3Bfrom+poison+to+remedy." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Botulinum+toxin%26%23x2014%3Bfrom+poison+to+remedy.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">3.
              </span><a name="pone.0000761-Springen1" id="pone.0000761-Springen1"></a>Springen K, Raymond J, Skipp C, Scelfo JSS (2002) The Botox boom. Newsweek 50–58.  <ul class="find" data-citedArticleID="979594"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=The+Botox+boom.&amp;auth=&amp;atitle=The+Botox+boom." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+Botox+boom." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+Botox+boom.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">4.
              </span><a name="pone.0000761-Singh1" id="pone.0000761-Singh1"></a>Singh BR (2000) Intimate details of the most poisonous poison. Nat Struct Biol  7: 617–619.  <ul class="find" data-citedArticleID="979592"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Intimate+details+of+the+most+poisonous+poison.&amp;auth=&amp;atitle=Intimate+details+of+the+most+poisonous+poison." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Intimate+details+of+the+most+poisonous+poison." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Intimate+details+of+the+most+poisonous+poison.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">5.
              </span><a name="pone.0000761-Simpson1" id="pone.0000761-Simpson1"></a>Simpson LL (1981) The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol Rev  33: 155–188.  <ul class="find" data-citedArticleID="979590"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=The+origin%2C+structure%2C+and+pharmacological+activity+of+botulinum+toxin.&amp;auth=&amp;atitle=The+origin%2C+structure%2C+and+pharmacological+activity+of+botulinum+toxin." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+origin%2C+structure%2C+and+pharmacological+activity+of+botulinum+toxin." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+origin%2C+structure%2C+and+pharmacological+activity+of+botulinum+toxin.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">6.
              </span><a name="pone.0000761-Burnett1" id="pone.0000761-Burnett1"></a>Burnett JC, Schmidt JJ, Stafford RG, Panchal RG, Nguyen TL, et al.  (2003) Novel small molecule inhibitors of botulinum neurotoxin A metalloprotease activity. Biochem Biophys Res Commun  310: 84–93.  <ul class="find" data-citedArticleID="979510" data-doi="10.1016/j.bbrc.2003.08.112"><li><a href="http://dx.doi.org/10.1016/j.bbrc.2003.08.112" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Novel+small+molecule+inhibitors+of+botulinum+neurotoxin+A+metalloprotease+activity." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Novel+small+molecule+inhibitors+of+botulinum+neurotoxin+A+metalloprotease+activity.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">7.
              </span><a name="pone.0000761-Park1" id="pone.0000761-Park1"></a>Park JG, Sill PC, Makiyi EF, Garcia-Sosa AT, Millard CB, et al.  (2006) Serotype-selective, small-molecule inhibitors of the zinc endopeptidase of botulinum neurotoxin serotype A. Bioorg Med Chem 14: 395–408.  <ul class="find" data-citedArticleID="979572" data-doi="10.1016/j.bmc.2005.08.018"><li><a href="http://dx.doi.org/10.1016/j.bmc.2005.08.018" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Serotype-selective%2C+small-molecule+inhibitors+of+the+zinc+endopeptidase+of+botulinum+neurotoxin+serotype+A.+Bioorg+Med+Chem" target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Serotype-selective%2C+small-molecule+inhibitors+of+the+zinc+endopeptidase+of+botulinum+neurotoxin+serotype+A.+Bioorg+Med+Chem%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">8.
              </span><a name="pone.0000761-Boldt1" id="pone.0000761-Boldt1"></a>Boldt GE, Eubanks LM, Janda KD (2006) Identification of a botulinum neurotoxin A protease inhibitor displaying efficacy in a cellular model. Chem Commun (Camb) 3063–3065.  <ul class="find" data-citedArticleID="979502" data-doi="10.1039/b603099h"><li><a href="http://dx.doi.org/10.1039/b603099h" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Identification+of+a+botulinum+neurotoxin+A+protease+inhibitor+displaying+efficacy+in+a+cellular+model." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Identification+of+a+botulinum+neurotoxin+A+protease+inhibitor+displaying+efficacy+in+a+cellular+model.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">9.
              </span><a name="pone.0000761-Boldt2" id="pone.0000761-Boldt2"></a>Boldt GE, Kennedy JP, Hixon MS, McAllister LA, Barbieri JT, et al.  (2006) Synthesis, characterization and development of a high-throughput methodology for the discovery of botulinum neurotoxin a inhibitors. J Comb Chem  8: 513–521.  <ul class="find" data-citedArticleID="979504" data-doi="10.1021/cc060010h"><li><a href="http://dx.doi.org/10.1021/cc060010h" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Synthesis%2C+characterization+and+development+of+a+high-throughput+methodology+for+the+discovery+of+botulinum+neurotoxin+a+inhibitors." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Synthesis%2C+characterization+and+development+of+a+high-throughput+methodology+for+the+discovery+of+botulinum+neurotoxin+a+inhibitors.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">10.
              </span><a name="pone.0000761-Boldt3" id="pone.0000761-Boldt3"></a>Boldt GE, Kennedy JP, Janda KD (2006) Identification of a potent botulinum neurotoxin a protease inhibitor using in situ lead identification chemistry. Org Lett  8: 1729–1732.  <ul class="find" data-citedArticleID="979506" data-doi="10.1021/ol0603211"><li><a href="http://dx.doi.org/10.1021/ol0603211" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Identification+of+a+potent+botulinum+neurotoxin+a+protease+inhibitor+using+in+situ+lead+identification+chemistry." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Identification+of+a+potent+botulinum+neurotoxin+a+protease+inhibitor+using+in+situ+lead+identification+chemistry.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">11.
              </span><a name="pone.0000761-Dickerson1" id="pone.0000761-Dickerson1"></a>Dickerson TJ, Janda KD (2006) The use of small molecules to investigate molecular mechanisms and therapeutic targets for treatment of botulinum neurotoxin A intoxication. Chem Biol  1: 359–369.  <ul class="find" data-citedArticleID="979518" data-doi="10.1021/cb600179d"><li><a href="http://dx.doi.org/10.1021/cb600179d" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+use+of+small+molecules+to+investigate+molecular+mechanisms+and+therapeutic+targets+for+treatment+of+botulinum+neurotoxin+A+intoxication." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+use+of+small+molecules+to+investigate+molecular+mechanisms+and+therapeutic+targets+for+treatment+of+botulinum+neurotoxin+A+intoxication.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">12.
              </span><a name="pone.0000761-Merino1" id="pone.0000761-Merino1"></a>Merino I, Thompson JD, Millard CB, Schmidt JJ, Pang Y-P (2006) Bis-imidazoles as molecular probes for peripheral sites of the zinc endopeptidase of botulinum neurotoxin serotype A. Bioorg Med Chem  14: 3583–3591.  <ul class="find" data-citedArticleID="979546" data-doi="10.1016/j.bmc.2006.01.015"><li><a href="http://dx.doi.org/10.1016/j.bmc.2006.01.015" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Bis-imidazoles+as+molecular+probes+for+peripheral+sites+of+the+zinc+endopeptidase+of+botulinum+neurotoxin+serotype+A." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Bis-imidazoles+as+molecular+probes+for+peripheral+sites+of+the+zinc+endopeptidase+of+botulinum+neurotoxin+serotype+A.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">13.
              </span><a name="pone.0000761-Johnson1" id="pone.0000761-Johnson1"></a>Johnson SL, Pellecchia M (2006) Structure- and fragment-based approaches to protease inhibition. Curr Top Med Chem  6: 317–329.  <ul class="find" data-citedArticleID="979536" data-doi="10.2174/156802606776287072"><li><a href="http://dx.doi.org/10.2174/156802606776287072" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Structure-+and+fragment-based+approaches+to+protease+inhibition." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Structure-+and+fragment-based+approaches+to+protease+inhibition.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">14.
              </span><a name="pone.0000761-Eubanks1" id="pone.0000761-Eubanks1"></a>Eubanks LM, Hixon MS, Jin W, Hong S, Clancy CM, et al.  (2007) An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonists. Proc Natl Acad Sci U S A.   <ul class="find" data-citedArticleID="979528" data-doi="10.1073/pnas.0611213104"><li><a href="http://dx.doi.org/10.1073/pnas.0611213104" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=An+in+vitro+and+in+vivo+disconnect+uncovered+through+high-throughput+identification+of+botulinum+neurotoxin+A+antagonists." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22An+in+vitro+and+in+vivo+disconnect+uncovered+through+high-throughput+identification+of+botulinum+neurotoxin+A+antagonists.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">15.
              </span><a name="pone.0000761-Burnett2" id="pone.0000761-Burnett2"></a>Burnett JC, Ruthel G, Stegmann CM, Panchal RG, Nguyen TL, et al.  (2007) Inhibition of metalloprotease botulinum serotype A from a pseudo-peptide binding mode to a small molecule that is active in primary neurons. J Biol Chem  282: 5004–5014.  <ul class="find" data-citedArticleID="979512" data-doi="10.1074/jbc.m608166200"><li><a href="http://dx.doi.org/10.1074/jbc.m608166200" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Inhibition+of+metalloprotease+botulinum+serotype+A+from+a+pseudo-peptide+binding+mode+to+a+small+molecule+that+is+active+in+primary+neurons." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Inhibition+of+metalloprotease+botulinum+serotype+A+from+a+pseudo-peptide+binding+mode+to+a+small+molecule+that+is+active+in+primary+neurons.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">16.
              </span><a name="pone.0000761-Arkin1" id="pone.0000761-Arkin1"></a>Arkin MR, Wells JA (2004) Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev Drug Dis  3: 301–317.  <ul class="find" data-citedArticleID="979498" data-doi="10.1038/nrd1343"><li><a href="http://dx.doi.org/10.1038/nrd1343" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Small-molecule+inhibitors+of+protein-protein+interactions%3A+progressing+towards+the+dream." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Small-molecule+inhibitors+of+protein-protein+interactions%3A+progressing+towards+the+dream.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">17.
              </span><a name="pone.0000761-Breidenbach1" id="pone.0000761-Breidenbach1"></a>Breidenbach MA, Brunger AT (2004) Substrate recognition strategy for botulinum neurotoxin serotype A. Nature  432: 925–929.  <ul class="find" data-citedArticleID="979508" data-doi="10.1038/nature03123"><li><a href="http://dx.doi.org/10.1038/nature03123" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Substrate+recognition+strategy+for+botulinum+neurotoxin+serotype+A." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Substrate+recognition+strategy+for+botulinum+neurotoxin+serotype+A.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">18.
              </span><a name="pone.0000761-Roe1" id="pone.0000761-Roe1"></a>Roe RR, Pang Y-P (1999) Zinc's exclusive tetrahedral coordination governed by its electronic structure. J Mol Model  5: 134–140.  <ul class="find" data-citedArticleID="979576" data-doi="10.1007/s008940050113"><li><a href="http://dx.doi.org/10.1007/s008940050113" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Zinc%27s+exclusive+tetrahedral+coordination+governed+by+its+electronic+structure." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Zinc%27s+exclusive+tetrahedral+coordination+governed+by+its+electronic+structure.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">19.
              </span><a name="pone.0000761-Pang1" id="pone.0000761-Pang1"></a>Pang YP (1999) Novel zinc protein molecular dynamics simulations: steps toward antiangiogenesis for cancer treatment. J Mol Model  5: 196–202.  <ul class="find" data-citedArticleID="979558" data-doi="10.1007/s008940050119"><li><a href="http://dx.doi.org/10.1007/s008940050119" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Novel+zinc+protein+molecular+dynamics+simulations%3A+steps+toward+antiangiogenesis+for+cancer+treatment." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Novel+zinc+protein+molecular+dynamics+simulations%3A+steps+toward+antiangiogenesis+for+cancer+treatment.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">20.
              </span><a name="pone.0000761-Pang2" id="pone.0000761-Pang2"></a>Pang YP, Xu K, El Yazal J, Prendergast FG (2000) Successful molecular dynamics simulation of the zinc-bound farnesyltransferase using the cationic dummy atom approach. Protein Sci  9: 1857–1865.  <ul class="find" data-citedArticleID="979560"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Successful+molecular+dynamics+simulation+of+the+zinc-bound+farnesyltransferase+using+the+cationic+dummy+atom+approach.&amp;auth=&amp;atitle=Successful+molecular+dynamics+simulation+of+the+zinc-bound+farnesyltransferase+using+the+cationic+dummy+atom+approach." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Successful+molecular+dynamics+simulation+of+the+zinc-bound+farnesyltransferase+using+the+cationic+dummy+atom+approach." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Successful+molecular+dynamics+simulation+of+the+zinc-bound+farnesyltransferase+using+the+cationic+dummy+atom+approach.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">21.
              </span><a name="pone.0000761-Pang3" id="pone.0000761-Pang3"></a>Pang Y-P (2001) Successful molecular dynamics simulation of two zinc complexes bridged by a hydroxide in phosphotriesterase using the cationic dummy atom method. Proteins  45: 183–189.  <ul class="find" data-citedArticleID="979562" data-doi="10.1002/prot.1138"><li><a href="http://dx.doi.org/10.1002/prot.1138" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Successful+molecular+dynamics+simulation+of+two+zinc+complexes+bridged+by+a+hydroxide+in+phosphotriesterase+using+the+cationic+dummy+atom+method." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Successful+molecular+dynamics+simulation+of+two+zinc+complexes+bridged+by+a+hydroxide+in+phosphotriesterase+using+the+cationic+dummy+atom+method.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">22.
              </span><a name="pone.0000761-Oelschlaeger1" id="pone.0000761-Oelschlaeger1"></a>Oelschlaeger P, Schmid RD, Pleiss J (2003) Insight into the mechanism of the IMP-1 metallo-beta-lactamase by molecular dynamics simulations. Protein Eng  16: 341–350.  <ul class="find" data-citedArticleID="979554" data-doi="10.1093/protein/gzg049"><li><a href="http://dx.doi.org/10.1093/protein/gzg049" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Insight+into+the+mechanism+of+the+IMP-1+metallo-beta-lactamase+by+molecular+dynamics+simulations." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Insight+into+the+mechanism+of+the+IMP-1+metallo-beta-lactamase+by+molecular+dynamics+simulations.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">23.
              </span><a name="pone.0000761-Oelschlaeger2" id="pone.0000761-Oelschlaeger2"></a>Oelschlaeger P, Schmid RD, Pleiss J (2003) Modeling domino effects in enzymes: molecular basis of the substrate specificity of the bacterial metallo-beta-lactamases IMP-1 and IMP-6. Biochemistry  42: 8945–8956.  <ul class="find" data-citedArticleID="979556" data-doi="10.1021/bi0300332"><li><a href="http://dx.doi.org/10.1021/bi0300332" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Modeling+domino+effects+in+enzymes%3A+molecular+basis+of+the+substrate+specificity+of+the+bacterial+metallo-beta-lactamases+IMP-1+and+IMP-6." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Modeling+domino+effects+in+enzymes%3A+molecular+basis+of+the+substrate+specificity+of+the+bacterial+metallo-beta-lactamases+IMP-1+and+IMP-6.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">24.
              </span><a name="pone.0000761-Pang4" id="pone.0000761-Pang4"></a>Pang YP, Miller JL, Kollman PA (1999) Computational and experimental studies of (2,2)-bis(indol-1-yl-methyl)acetate suggest the importance of the hydrophobic effect in aromatic stacking interactions. J Am Chem Soc  121: 1717–1725.  <ul class="find" data-citedArticleID="979564" data-doi="10.1021/ja9828410"><li><a href="http://dx.doi.org/10.1021/ja9828410" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Computational+and+experimental+studies+of+%282%2C2%29-bis%28indol-1-yl-methyl%29acetate+suggest+the+importance+of+the+hydrophobic+effect+in+aromatic+stacking+interactions." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Computational+and+experimental+studies+of+%282%2C2%29-bis%28indol-1-yl-methyl%29acetate+suggest+the+importance+of+the+hydrophobic+effect+in+aromatic+stacking+interactions.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">25.
              </span><a name="pone.0000761-Jorgensen1" id="pone.0000761-Jorgensen1"></a>Jorgensen WL, Chandreskhar J, Madura JD, Impey RW, Klein ML (1982) Comparison of simple potential functions for simulating liquid water. J Chem Phys  79: 926–935.  <ul class="find" data-citedArticleID="979538" data-doi="10.1063/1.445869"><li><a href="http://dx.doi.org/10.1063/1.445869" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Comparison+of+simple+potential+functions+for+simulating+liquid+water." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Comparison+of+simple+potential+functions+for+simulating+liquid+water.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">26.
              </span><a name="pone.0000761-Miyaura1" id="pone.0000761-Miyaura1"></a>Miyaura N, Suzuki A (1979) Stereoselective synthesis of arylated (E)-alkenes by the reaction of alk-1-enylboranes with aryl halides in the presence of palladium catalyst. J Chem Soc, Chem Commun 866–867.  <ul class="find" data-citedArticleID="979548" data-doi="10.1039/c39790000866"><li><a href="http://dx.doi.org/10.1039/c39790000866" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Stereoselective+synthesis+of+arylated+%28E%29-alkenes+by+the+reaction+of+alk-1-enylboranes+with+aryl+halides+in+the+presence+of+palladium+catalyst." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Stereoselective+synthesis+of+arylated+%28E%29-alkenes+by+the+reaction+of+alk-1-enylboranes+with+aryl+halides+in+the+presence+of+palladium+catalyst.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">27.
              </span><a name="pone.0000761-Suzuki1" id="pone.0000761-Suzuki1"></a>Suzuki A (1991) Synthetic studies via the cross-coupling reaction of organoboron derivatives with organic halides. Pure Appl Chem  63: 419–422.  <ul class="find" data-citedArticleID="979596" data-doi="10.1351/pac199163030419"><li><a href="http://dx.doi.org/10.1351/pac199163030419" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Synthetic+studies+via+the+cross-coupling+reaction+of+organoboron+derivatives+with+organic+halides." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Synthetic+studies+via+the+cross-coupling+reaction+of+organoboron+derivatives+with+organic+halides.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">28.
              </span><a name="pone.0000761-Miyaura2" id="pone.0000761-Miyaura2"></a>Miyaura N, Suzuki A (1995) Palladium-catalyzed cross-coupling reactions of organoboron compounds. Chem Rev  95: 2457–2483.  <ul class="find" data-citedArticleID="979550" data-doi="10.1021/cr00039a007"><li><a href="http://dx.doi.org/10.1021/cr00039a007" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Palladium-catalyzed+cross-coupling+reactions+of+organoboron+compounds." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Palladium-catalyzed+cross-coupling+reactions+of+organoboron+compounds.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">29.
              </span><a name="pone.0000761-Joule1" id="pone.0000761-Joule1"></a>Joule JA, Mills K, Smith GF (1998) Heterocyclic Chemistry. Cheltenham: Stanley Thornes.   <ul class="find-nolinks"></ul></li><li><span class="label">30.
              </span><a name="pone.0000761-Gupta1" id="pone.0000761-Gupta1"></a>Gupta RR, Kumar M, Gupta V (1999) Heterocyclic Chemistry. Volume II. Berlin: Springer. pp. 145–147.  <ul class="find-nolinks"></ul></li><li><span class="label">31.
              </span><a name="pone.0000761-Dieck1" id="pone.0000761-Dieck1"></a>Dieck HA, Heck FR (1975) Palladium catalyzed synthesis of aryl heterocyclic and vinylic acetylene derivatives. J Organomet Chem  93: 259–263.  <ul class="find" data-citedArticleID="979520" data-doi="10.1016/s0022-328x(00)94049-x"><li><a href="http://dx.doi.org/10.1016/s0022-328x(00)94049-x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Palladium+catalyzed+synthesis+of+aryl+heterocyclic+and+vinylic+acetylene+derivatives." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Palladium+catalyzed+synthesis+of+aryl+heterocyclic+and+vinylic+acetylene+derivatives.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">32.
              </span><a name="pone.0000761-Sakai1" id="pone.0000761-Sakai1"></a>Sakai N, Annaka K, Konakahara T (2004) Palladium-catalyzed coupling reaction of terminal alkynes with aryl iodides in the presence of indium tribromide and its application to a one-pot synthesis of 2-phenylindole. Org Lett  6: 1527–1530.  <ul class="find" data-citedArticleID="979578" data-doi="10.1021/ol036499u"><li><a href="http://dx.doi.org/10.1021/ol036499u" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Palladium-catalyzed+coupling+reaction+of+terminal+alkynes+with+aryl+iodides+in+the+presence+of+indium+tribromide+and+its+application+to+a+one-pot+synthesis+of+2-phenylindole." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Palladium-catalyzed+coupling+reaction+of+terminal+alkynes+with+aryl+iodides+in+the+presence+of+indium+tribromide+and+its+application+to+a+one-pot+synthesis+of+2-phenylindole.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">33.
              </span><a name="pone.0000761-Meegalla1" id="pone.0000761-Meegalla1"></a>Meegalla SK, Doller D, Sha D, Soll R, Wisnewski N, et al.  (2004) Synthesis and GABA receptor potency of 3-thiomethyl-4-(hetero)aryl-5-amino-1-ph​enylpyrazoles. Bioorg Med Chem Lett  14: 4949–4953.  <ul class="find" data-citedArticleID="979544" data-doi="10.1016/j.bmcl.2004.07.033"><li><a href="http://dx.doi.org/10.1016/j.bmcl.2004.07.033" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Synthesis+and+GABA+receptor+potency+of+3-thiomethyl-4-%28hetero%29aryl-5-amino-1-phenylpyrazoles." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Synthesis+and+GABA+receptor+potency+of+3-thiomethyl-4-%28hetero%29aryl-5-amino-1-phenylpyrazoles.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">34.
              </span><a name="pone.0000761-Ho1" id="pone.0000761-Ho1"></a>Ho CY, Strobel E, Ralbovsky J, Galemmo RA Jr (2005) Improved solution- and solid-phase preparation of hydroxamic acids from esters. J Org Chem  70: 4873–4875.  <ul class="find" data-citedArticleID="979534" data-doi="10.1021/jo050036f"><li><a href="http://dx.doi.org/10.1021/jo050036f" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Improved+solution-+and+solid-phase+preparation+of+hydroxamic+acids+from+esters." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Improved+solution-+and+solid-phase+preparation+of+hydroxamic+acids+from+esters.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">35.
              </span><a name="pone.0000761-Mootoo1" id="pone.0000761-Mootoo1"></a>Mootoo DR, Fraiser-Reid B (1989) n-Pentenyl 2-amino-2-deoxy glycosides undergo stereoselective coupling under mild, chemospecific conditions. Tetrahedron Lett  30: 2363.  <ul class="find" data-citedArticleID="979552" data-doi="10.1016/s0040-4039(01)80399-3"><li><a href="http://dx.doi.org/10.1016/s0040-4039(01)80399-3" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=n-Pentenyl+2-amino-2-deoxy+glycosides+undergo+stereoselective+coupling+under+mild%2C+chemospecific+conditions." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22n-Pentenyl+2-amino-2-deoxy+glycosides+undergo+stereoselective+coupling+under+mild%2C+chemospecific+conditions.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">36.
              </span><a name="pone.0000761-Ariffin1" id="pone.0000761-Ariffin1"></a>Ariffin A, Khan MN, Lan LC, May FY, Yun CS (2004) Suggested improved method for the Ing-Manske and related reactions for the second step of Gabriel synthesis of primary amines. Synth Commun  34: 4439–4445.  <ul class="find" data-citedArticleID="979496" data-doi="10.1081/scc-200043164"><li><a href="http://dx.doi.org/10.1081/scc-200043164" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Suggested+improved+method+for+the+Ing-Manske+and+related+reactions+for+the+second+step+of+Gabriel+synthesis+of+primary+amines." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Suggested+improved+method+for+the+Ing-Manske+and+related+reactions+for+the+second+step+of+Gabriel+synthesis+of+primary+amines.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">37.
              </span><a name="pone.0000761-Schmidt1" id="pone.0000761-Schmidt1"></a>Schmidt JJ, Bostian KA (1997) Endoproteinase activity of type A botulinum neurotoxin: substrate requirements and activation by serum albumin. J Protein Chem  16: 19–26.  <ul class="find" data-citedArticleID="979580"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Endoproteinase+activity+of+type+A+botulinum+neurotoxin%3A+substrate+requirements+and+activation+by+serum+albumin.&amp;auth=&amp;atitle=Endoproteinase+activity+of+type+A+botulinum+neurotoxin%3A+substrate+requirements+and+activation+by+serum+albumin." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Endoproteinase+activity+of+type+A+botulinum+neurotoxin%3A+substrate+requirements+and+activation+by+serum+albumin." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Endoproteinase+activity+of+type+A+botulinum+neurotoxin%3A+substrate+requirements+and+activation+by+serum+albumin.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">38.
              </span><a name="pone.0000761-Todhunter1" id="pone.0000761-Todhunter1"></a>Todhunter JA (1979) Reversible enzyme inhibition. Methods in Enzymology  63: 383–411.  <ul class="find" data-citedArticleID="979598" data-doi="10.1016/0076-6879(79)63017-3"><li><a href="http://dx.doi.org/10.1016/0076-6879(79)63017-3" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Reversible+enzyme+inhibition." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Reversible+enzyme+inhibition.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">39.
              </span><a name="pone.0000761-Shapiro2" id="pone.0000761-Shapiro2"></a>Shapiro R, Riordan JF (1984) Inhibition of angiotensin converting enzyme: mechanism and substrate dependence. Biochemistry  23: 5225–5233.  <ul class="find" data-citedArticleID="979586" data-doi="10.1021/bi00317a021"><li><a href="http://dx.doi.org/10.1021/bi00317a021" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Inhibition+of+angiotensin+converting+enzyme%3A+mechanism+and+substrate+dependence." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Inhibition+of+angiotensin+converting+enzyme%3A+mechanism+and+substrate+dependence.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">40.
              </span><a name="pone.0000761-Pang5" id="pone.0000761-Pang5"></a>Pang Y-P, Quiram P, Jelacic T, Hong F, Brimijoin S (1996) Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase: steps toward novel drugs for treating Alzheimer's disease. J Biol Chem  271: 23646–23649.  <ul class="find" data-citedArticleID="979566" data-doi="10.1074/jbc.271.39.23646"><li><a href="http://dx.doi.org/10.1074/jbc.271.39.23646" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Highly+potent%2C+selective%2C+and+low+cost+bis-tetrahydroaminacrine+inhibitors+of+acetylcholinesterase%3A+steps+toward+novel+drugs+for+treating+Alzheimer%27s+disease." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Highly+potent%2C+selective%2C+and+low+cost+bis-tetrahydroaminacrine+inhibitors+of+acetylcholinesterase%3A+steps+toward+novel+drugs+for+treating+Alzheimer%27s+disease.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">41.
              </span><a name="pone.0000761-Pang6" id="pone.0000761-Pang6"></a>Pang Y-P (2004) Nonbonded bivalence approach to cell-permeable molecules that target DNA sequences. Bioorg Med Chem  12: 3063–3068.  <ul class="find" data-citedArticleID="979568" data-doi="10.1016/j.bmc.2004.02.026"><li><a href="http://dx.doi.org/10.1016/j.bmc.2004.02.026" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Nonbonded+bivalence+approach+to+cell-permeable+molecules+that+target+DNA+sequences." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Nonbonded+bivalence+approach+to+cell-permeable+molecules+that+target+DNA+sequences.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">42.
              </span><a name="pone.0000761-ElYazal1" id="pone.0000761-ElYazal1"></a>El Yazal J, Pang YP (1999) <em>Ab initio</em> calculations of proton dissociation energies of zinc ligands: hypothesis of imidazolate as zinc ligand in proteins. J Phys Chem B  103: 8773–8779.  <ul class="find" data-citedArticleID="979522" data-doi="10.1021/jp991787m"><li><a href="http://dx.doi.org/10.1021/jp991787m" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Ab+initio+calculations+of+proton+dissociation+energies+of+zinc+ligands%3A+hypothesis+of+imidazolate+as+zinc+ligand+in+proteins." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Ab+initio+calculations+of+proton+dissociation+energies+of+zinc+ligands%3A+hypothesis+of+imidazolate+as+zinc+ligand+in+proteins.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">43.
              </span><a name="pone.0000761-ElYazal2" id="pone.0000761-ElYazal2"></a>El Yazal J, Roe RR, Pang Y-P (2000) Zinc's affect on proton transfer between imidazole and acetate predicted by ab initio calculations. J Phys Chem B  104: 6662–6667.  <ul class="find" data-citedArticleID="979524" data-doi="10.1021/jp994283x"><li><a href="http://dx.doi.org/10.1021/jp994283x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Zinc%27s+affect+on+proton+transfer+between+imidazole+and+acetate+predicted+by+ab+initio+calculations." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Zinc%27s+affect+on+proton+transfer+between+imidazole+and+acetate+predicted+by+ab+initio+calculations.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">44.
              </span><a name="pone.0000761-ElYazal3" id="pone.0000761-ElYazal3"></a>El Yazal J, Pang YP (2001) Comparison of DFT, Moller-Plesset, and coupled cluster calculations of the proton dissociation energies of imidazole and N-methylacetamide in the presence of zinc(II). J Mol Struct (Theochem),  545: 271–274.  <ul class="find" data-citedArticleID="979526" data-doi="10.1016/s0166-1280(01)00405-5"><li><a href="http://dx.doi.org/10.1016/s0166-1280(01)00405-5" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Comparison+of+DFT%2C+Moller-Plesset%2C+and+coupled+cluster+calculations+of+the+proton+dissociation+energies+of+imidazole+and+N-methylacetamide+in+the+presence+of+zinc%28II%29." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Comparison+of+DFT%2C+Moller-Plesset%2C+and+coupled+cluster+calculations+of+the+proton+dissociation+energies+of+imidazole+and+N-methylacetamide+in+the+presence+of+zinc%28II%29.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">45.
              </span><a name="pone.0000761-Pearlman1" id="pone.0000761-Pearlman1"></a>Pearlman DA, Case DA, Caldwell JW, Ross WS, Cheatham TE III, et al.  (1995) AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules. Comput Phys Commun  91: 1–41.  <ul class="find" data-citedArticleID="979574" data-doi="10.1016/0010-4655(95)00041-d"><li><a href="http://dx.doi.org/10.1016/0010-4655(95)00041-d" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=AMBER%2C+a+package+of+computer+programs+for+applying+molecular+mechanics%2C+normal+mode+analysis%2C+molecular+dynamics+and+free+energy+calculations+to+simulate+the+structural+and+energetic+properties+of+molecules." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22AMBER%2C+a+package+of+computer+programs+for+applying+molecular+mechanics%2C+normal+mode+analysis%2C+molecular+dynamics+and+free+energy+calculations+to+simulate+the+structural+and+energetic+properties+of+molecules.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">46.
              </span><a name="pone.0000761-Frisch1" id="pone.0000761-Frisch1"></a>Frisch MJ, Trucks GW, Schlegel HB, Gill PMW, Hohnson BG, et al.  (1999) GAUSSIAN 98, Revision A.7. Pittsburgh, PA: Gaussian, Inc.   <ul class="find-nolinks"></ul></li><li><span class="label">47.
              </span><a name="pone.0000761-Pang7" id="pone.0000761-Pang7"></a>Pang Y-P (2004) Three-dimensional model of a substrate-bound SARS chymotrypsin-like cysteine proteinase predicted by multiple molecular dynamics simulations: catalytic efficiency regulated by substrate binding. Proteins  57: 747–757.  <ul class="find" data-citedArticleID="979570" data-doi="10.1002/prot.20249"><li><a href="http://dx.doi.org/10.1002/prot.20249" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Three-dimensional+model+of+a+substrate-bound+SARS+chymotrypsin-like+cysteine+proteinase+predicted+by+multiple+molecular+dynamics+simulations%3A+catalytic+efficiency+regulated+by+substrate+binding." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Three-dimensional+model+of+a+substrate-bound+SARS+chymotrypsin-like+cysteine+proteinase+predicted+by+multiple+molecular+dynamics+simulations%3A+catalytic+efficiency+regulated+by+substrate+binding.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">48.
              </span><a name="pone.0000761-Cornell1" id="pone.0000761-Cornell1"></a>Cornell WD, Cieplak P, Bayly CI, Gould IR, Merz KM Jr, et al.  (1995) A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. J Am Chem Soc  117: 5179–5197.  <ul class="find" data-citedArticleID="979514" data-doi="10.1021/ja00124a002"><li><a href="http://dx.doi.org/10.1021/ja00124a002" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+second+generation+force+field+for+the+simulation+of+proteins%2C+nucleic+acids%2C+and+organic+molecules." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+second+generation+force+field+for+the+simulation+of+proteins%2C+nucleic+acids%2C+and+organic+molecules.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">49.
              </span><a name="pone.0000761-Berendsen1" id="pone.0000761-Berendsen1"></a>Berendsen HJC, Postma JPM, van Gunsteren WF, Di Nola A, Haak JR (1984) Molecular dynamics with coupling to an external bath. J Chem Phys  81: 3684–3690.  <ul class="find" data-citedArticleID="979500" data-doi="10.1063/1.448118"><li><a href="http://dx.doi.org/10.1063/1.448118" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Molecular+dynamics+with+coupling+to+an+external+bath." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Molecular+dynamics+with+coupling+to+an+external+bath.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">50.
              </span><a name="pone.0000761-Darden1" id="pone.0000761-Darden1"></a>Darden TA, York DM, Pedersen LG (1993) Particle Mesh Ewald: An N log(N) method for Ewald sums in large systems. J Chem Phys  98: 10089–10092.  <ul class="find" data-citedArticleID="979516" data-doi="10.1063/1.464397"><li><a href="http://dx.doi.org/10.1063/1.464397" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Particle+Mesh+Ewald%3A+An+N+log%28N%29+method+for+Ewald+sums+in+large+systems." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Particle+Mesh+Ewald%3A+An+N+log%28N%29+method+for+Ewald+sums+in+large+systems.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">51.
              </span><a name="pone.0000761-Shone1" id="pone.0000761-Shone1"></a>Shone CC, Roberts AK (1994) Peptide substrate specificity and properties of the zinc-endopeptidase activity of botulinum type B neurotoxin. Eur J Biochem  225: 263–270.  <ul class="find" data-citedArticleID="979588" data-doi="10.1111/j.1432-1033.1994.00263.x"><li><a href="http://dx.doi.org/10.1111/j.1432-1033.1994.00263.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Peptide+substrate+specificity+and+properties+of+the+zinc-endopeptidase+activity+of+botulinum+type+B+neurotoxin." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Peptide+substrate+specificity+and+properties+of+the+zinc-endopeptidase+activity+of+botulinum+type+B+neurotoxin.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">52.
              </span><a name="pone.0000761-Schmidt2" id="pone.0000761-Schmidt2"></a>Schmidt JJ, Stafford RG (2003) Fluorigenic substrates for the protease activities of botulinum neurotoxins, serotypes A, B, and F. Appl Environ Microbiol  69: 297–303.  <ul class="find" data-citedArticleID="979582" data-doi="10.1128/aem.69.1.297-303.2003"><li><a href="http://dx.doi.org/10.1128/aem.69.1.297-303.2003" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Fluorigenic+substrates+for+the+protease+activities+of+botulinum+neurotoxins%2C+serotypes+A%2C+B%2C+and+F." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Fluorigenic+substrates+for+the+protease+activities+of+botulinum+neurotoxins%2C+serotypes+A%2C+B%2C+and+F.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li></ol></div>

  </div>

      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.XML" value="93482"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.PDF" value="264508"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.g001.PNG_L" value="33538"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.g001.PNG_M" value="22438"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.g001.PNG_S" value="5615"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.g001.TIF" value="55322"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.g001.PNG_I" value="8474"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.g002.PNG_L" value="747762"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.g002.PNG_M" value="211954"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.g002.PNG_S" value="13885"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.g002.TIF" value="1070844"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.g002.PNG_I" value="73895"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.g003.PNG_L" value="71885"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.g003.PNG_M" value="23388"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.g003.PNG_S" value="4643"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.g003.TIF" value="126206"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.g003.PNG_I" value="8403"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.g004.PNG_L" value="207146"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.g004.PNG_M" value="44849"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.g004.PNG_S" value="5862"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.g004.TIF" value="377876"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.g004.PNG_I" value="15142"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.g005.PNG_L" value="183580"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.g005.PNG_M" value="38651"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.g005.PNG_S" value="6688"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.g005.TIF" value="273858"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.g005.PNG_I" value="13037"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.e001.PNG" value="8701"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.e001.TIF" value="24832"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.s001.DOC" value="151040"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.s002.DOC" value="123392"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.s003.TIF" value="9494806"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000761.s004.TIF" value="1326792"/>

</div>
<div class="sidebar">

  <div class="article-actions cf">
      <div class="download">
        <span class="btn"><a href="/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0000761&amp;representation=PDF" title="Download" target="_blank">Download PDF</a></span>
      </div>
      <div class="btn-reveal dropdown">
        <div class="dropdown-icon">
          <span class="btn">&nbsp;</span>
        </div>

        <div class="content">
          <ul class="bullet">
            <li><a href="/article/citationList.action?articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0000761" title="Download citations">Citation</a></li>
            <li><a href="/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0000761&amp;representation=XML" title="Download article XML">XML</a></li>
          </ul>
        </div>
      </div> <!-- end btn-reveal dropdown-->


    <div class="btn-reveal flt-l">
        <span class="btn">Print</span>
        <div class="content">
            <ul class="bullet">
                <li id="print-article"><a href="#" onclick="if(typeof(_gaq) != 'undefined'){ _gaq.push(['_trackEvent','Article', 'Print', 'Click']); } window.print(); return false;" title="Print Article">Print article</a></li>
                <li>
                  <a href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=7&doi=10.1371/journal.pone.0000761&volume=&issue=&title=Computer-Aided Lead Optimization: Improved Small-Molecule Inhibitor of the Zinc Endopeptidase of Botulinum Neurotoxin Serotype A&author_name=Jing%20Tang%2C%20Jewn%20Giew%20Park%2C%20Charles%20B.%20Millard%2C%20James%20J.%20Schmidt%2C%20Yuan-Ping%20Pang&start_page=1&end_page=8" title="Odyssey Press">EzReprint</a>
                </li>
            </ul>
        </div>
    </div>

    <div class="btn-reveal flt-r">
        <span class="btn">Share</span>
        <div class="content">
            <ul class="social">
                <li><a href="http://www.reddit.com/submit?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000761" target="_blank" title="Submit to Reddit"><img src="/images/icon.reddit.16.png" width="16" height="16" alt="Reddit">Reddit</a></li>

                <li><a href="https://plus.google.com/share?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000761" target="_blank" title="Share on Google+"><img src="/images/icon.gplus.16.png" width="16" height="16" alt="Google+">Google+</a></li>

                <li><a href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.plosone.org%2Farticle%2Finfo%253Adoi%252F10.1371%252Fjournal.pone.0000761" target="_blank" title="Add to StumbleUpon"><img src="/images/icon.stumble.16.png" width="16" height="16" alt="StumbleUpon">StumbleUpon</a></li>

                <li><a href="http://www.facebook.com/share.php?u=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000761&amp;t=Computer-Aided%20Lead%20Optimization%3A%20Improved%20Small-Molecule%20Inhibitor%20of%20the%20Zinc%20Endopeptidase%20of%20Botulinum%20Neurotoxin%20Serotype%20A" target="_blank" title="Share on Facebook"><img src="/images/icon.fb.16.png" width="16" height="16" alt="Facebook">Facebook</a></li>

                <li><a href="http://www.linkedin.com/shareArticle?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000761&title=Computer-Aided%20Lead%20Optimization%3A%20Improved%20Small-Molecule%20Inhibitor%20of%20the%20Zinc%20Endopeptidase%20of%20Botulinum%20Neurotoxin%20Serotype%20A&summary=Checkout%20this%20article%20I%20found%20at%20PLOS" target="_blank" title="Add to LinkedIn"><img src="/images/icon.linkedin.16.png" width="16" height="16" alt="Mendeley">LinkedIn</a></li>

                <li><a href="http://www.citeulike.org/posturl?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000761&amp;title=Computer-Aided%20Lead%20Optimization%3A%20Improved%20Small-Molecule%20Inhibitor%20of%20the%20Zinc%20Endopeptidase%20of%20Botulinum%20Neurotoxin%20Serotype%20A" target="_blank" title="Add to CiteULike"><img src="/images/icon.cul.16.png" width="16" height="16" alt="CiteULike">CiteULike</a></li>

                <li><a href="http://www.mendeley.com/import/?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000761" target="_blank" title="Add to Mendeley"><img src="/images/icon.mendeley.16.png" width="16" height="16" alt="Mendeley">Mendeley</a></li>

                <li><a href="https://www.pubchase.com/library?add_aid=10.1371%2Fjournal.pone.0000761&amp;source=plos" target="_blank" title="Add to PubChase"><img src="/images/icon.pc.16.png" width="16" height="16" alt="PubChase">PubChase</a></li>


                <script type="text/javascript">
                    // replace tweet with one that's pre-shortened to 140 chars
                    function truncateTweetText() {
                        var twtTitle = 'Computer-Aided Lead Optimization: Improved Small-Molecule Inhibitor of the Zinc Endopeptidase of Botulinum Neurotoxin Serotype A';
                        var twtUrl = 'http://dx.plos.org/10.1371/journal.pone.0000761';
                        // all URLs posted to twitter get auto-shortened to 20 chars.
                        var maxLength = 140 - (20 + 1);
                        // truncate the title to include space for twtTag and ellipsis (here, 10 = tag length + space + ellipsis)
                        if (twtTitle.length > maxLength) { twtTitle = twtTitle.substr(0, (maxLength - 10)) + '...'; }
                        // set the href to use the shortened tweet
                        $('#twitter-share-link').prop('href', 'http://twitter.com/intent/tweet?text=' + encodeURIComponent('#PLOSONE: ' + twtTitle + ' ' + twtUrl));
                    }
                </script>
                <li><a href="http://twitter.com/intent/tweet?text=#PLOSONE%3A%20Computer-Aided%20Lead%20Optimization%3A%20Improved%20Small-Molecule%20Inhibitor%20of%20the%20Zinc%20Endopeptidase%20of%20Botulinum%20Neurotoxin%20Serotype%20A http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000761" onclick="truncateTweetText();" target="_blank" title="Share on Twitter" id="twitter-share-link"><img src="/images/icon.twtr.16.png" width="16" height="16" alt="Twitter">Twitter</a></li>

                <li><a href="/article/email/info%3Adoi%2F10.1371%2Fjournal.pone.0000761" title="Email this article"><img src="/images/icon.email.16.png" width="16" height="16" alt="Email">Email</a></li>
            </ul>
        </div>
    </div><!--end btn-reveal flt-r-->
</div><!-- end article-actions-->

<!-- begin Crossmark -->

<a id="open-crossmark" href="#" style="margin-top: -28px; display:block"><img style="border: 0; display: none;
 padding: 10px 0 18px 0;"  id="crossmark-icon" src="/images/logo-crossmark-bw.png" /></a>
<div id="crossmark-dialog" style="display: none;" title="">
    <!-- the external CrossMark data is loaded inside this iframe -->
    <iframe id="crossmark-dialog-frame" frameborder="0"></iframe>
</div>

<!-- end crossmark -->


<div class="block" id="subject-area-sidebar-block">
    <div class="header">
        <h3>Subject Areas</h3><div title="More information" id="subject-area-sidebar-block-help-icon"><img align="right"
                                                                                                           alt="info" src="/images/button_info.png"/><div id="subject-area-sidebar-block-help"><img align="right"
                                                                                                                                                                                                    src="/images/button_info.png"/><p>
        <b>We want your feedback.</b> Do these subject areas make sense for this article? If not, click the flag
        next to the incorrect subject area and we will review it. Thanks for your help!
    </p></div></div>
    </div>


    <ul id="subject-area-sidebar-list">











          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Cations%22" title="Search for articles in the subject area:'Cations'"><div class="flagText">Cations</div></a>
              <div data-categoryid="20049" data-articleid="24360"
                   data-categoryname="Cations"
                   class="flagImage" title="Flag 'Cations' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Competitive+inhibitors%22" title="Search for articles in the subject area:'Competitive inhibitors'"><div class="flagText">Competitive inhibitors</div></a>
              <div data-categoryid="24251" data-articleid="24360"
                   data-categoryname="Competitive inhibitors"
                   class="flagImage" title="Flag 'Competitive inhibitors' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Free+energy%22" title="Search for articles in the subject area:'Free energy'"><div class="flagText">Free energy</div></a>
              <div data-categoryid="18159" data-articleid="24360"
                   data-categoryname="Free energy"
                   class="flagImage" title="Flag 'Free energy' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22High+performance+liquid+chromatography%22" title="Search for articles in the subject area:'High performance liquid chromatography'"><div class="flagText">High performance liquid chromatography</div></a>
              <div data-categoryid="20319" data-articleid="24360"
                   data-categoryname="High performance liquid chromatography"
                   class="flagImage" title="Flag 'High performance liquid chromatography' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Molecular+dynamics%22" title="Search for articles in the subject area:'Molecular dynamics'"><div class="flagText">Molecular dynamics</div></a>
              <div data-categoryid="18025" data-articleid="24360"
                   data-categoryname="Molecular dynamics"
                   class="flagImage" title="Flag 'Molecular dynamics' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Neurotoxins%22" title="Search for articles in the subject area:'Neurotoxins'"><div class="flagText">Neurotoxins</div></a>
              <div data-categoryid="21425" data-articleid="24360"
                   data-categoryname="Neurotoxins"
                   class="flagImage" title="Flag 'Neurotoxins' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Nuclear+magnetic+resonance%22" title="Search for articles in the subject area:'Nuclear magnetic resonance'"><div class="flagText">Nuclear magnetic resonance</div></a>
              <div data-categoryid="19999" data-articleid="24360"
                   data-categoryname="Nuclear magnetic resonance"
                   class="flagImage" title="Flag 'Nuclear magnetic resonance' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Optimization%22" title="Search for articles in the subject area:'Optimization'"><div class="flagText">Optimization</div></a>
              <div data-categoryid="31839" data-articleid="24360"
                   data-categoryname="Optimization"
                   class="flagImage" title="Flag 'Optimization' as inappropriate"></div>
          </li>
    </ul>
</div>

<div class="ad">
    <div class="title">Advertisement</div>






  <iframe id='a0852f54' name='a0852f54'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=381&amp;cb=9947'
    frameborder='0' scrolling='no' width='160' height='600'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a0852f54&amp;cb=1179'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=381&amp;cb=9879&amp;n=a0852f54'
      border='0' alt=''/>
    </a>
  </iframe>



</div>

<div id="twitter-alm-timeline" class="twitter-alm-timeline"></div>


</div><!-- sidebar -->
    </div>
  </div>
</div>
<script src="http://wl.figshare.com/static/p_widget.js" type="text/javascript"></script><div id="pageftr">
  <div class="ftr-cols cf">
    <div class="col col-1">
      <img src="/images/logo-plos-footer.png" alt="PLOS Logo" class="logo" />
      <p><a href="/static/releaseNotes">Ambra 2.9.16</a> Managed Colocation provided <br />by <a href="http://www.isc.org/">Internet Systems Consortium</a>.<p>
      <div class="nav nav-aux">
        <a href="/static/privacy">Privacy Policy</a> |
        <a href="/static/terms">Terms of Use</a> |
        <a href="http://www.plos.org/advertise/">Advertise</a> |
        <a href="http://www.plos.org/about/media-inquiries/">Media Inquiries</a>
      </div>
    </div>
    <div class="col col-2">
      <p><a href="http://www.plos.org/publications/journals/">Publications</a></p>
      <div class="nav">
        <ul>
          <li><a href="http://www.plosbiology.org">PLOS Biology</a></li>
          <li><a href="http://www.plosmedicine.org">PLOS Medicine</a></li>
          <li><a href="http://www.ploscompbiol.org">PLOS Computational Biology</a></li>
          <li><a href="http://currents.plos.org">PLOS Currents</a></li>
          <li><a href="http://www.plosgenetics.org">PLOS Genetics</a></li>
          <li><a href="http://www.plospathogens.org">PLOS Pathogens</a></li>
          <li><a href="http://www.plosone.org">PLOS ONE</a></li>
          <li><a href="http://www.plosntds.org">PLOS Neglected Tropical Diseases</a></li>
        </ul>
      </div>
    </div>
    <div class="col col-3">
      <div class="nav">
        <p><a href="http://www.plos.org">plos.org</a></p>
        <p><a href="http://blogs.plos.org">Blogs</a></p>
        <p><a href="http://www.ploscollections.org">Collections</a></p>
        <p><a href="/feedback/new">Send us feedback</a></p>

        <p>California (US) corporation #C2354500, based in San Francisco</p>
      </div>
    </div>
  </div>
</div><!-- pageftr -->

</div><!-- end page-wrap, this div is in header.ftl -->
<script type="text/javascript" src="/javascript/jquery-1.8.1-min.js?v=Tm7VCOzZz3lE03ghpkS6SWkHbyI"></script>
<script type="text/javascript" src="/javascript/ga-min.js?v=lNQ4gt8QcPDatjsdOFl_FGpPhLY"></script>
<script type="text/javascript" src="/javascript/jquery.hoverIntent-min.js?v=mRiGNYY9cIXxVb8u0K_MdW7hHnc"></script>
<script type="text/javascript" src="/javascript/jquery.placeholder-min.js?v=21Pn56Ur9h1N4K4VZDa0nqI3Pxo"></script>
<script type="text/javascript" src="/javascript/jquery.jsonp-2.4.0-min.js?v=lqTpzoHfSq3I5Ygo01qq5WankEo"></script>
<script type="text/javascript" src="/javascript/jquery-ui-1.9.2.custom-min.js?v=raSSlfNO0YsV5uUpAKmTB9n5VTc"></script>
<script type="text/javascript" src="/javascript/jquery.tooltip-min.js?v=cw+6Smh+mdryIA25xvqIvHMrnZM"></script>
<script type="text/javascript" src="/javascript/jquery.uniform-min.js?v=kYUAnX6W2W_2fK3RIuQ2m_YFG9U"></script>
<script type="text/javascript" src="/javascript/jquery.pjax-min.js?v=939kLBjL5_YKbx71T1RHjYaD4l8"></script>
<script type="text/javascript" src="/javascript/imagesloaded-min.js?v=XeuAp8Gc3mvQUo+wZCSF8ttPwvw"></script>
<script type="text/javascript" src="/javascript/figviewer-min.js?v=yPUa0sUQ_iHkI+IRv2i9bjyZJFo"></script>
<script type="text/javascript" src="/javascript/global-min.js?v=0Q3PwjeaWtXYDnqIsQvnL_ou0qs"></script>
<script type="text/javascript" src="/javascript/jquery.touchswipe-min.js?v=huaek_e6HqTduvCNAN91dJolTyw"></script>
<script type="text/javascript" src="/javascript/jquery.base64-min.js?v=VwV1zeVqKZj5FCAdlK0q5NRxbBg"></script>
<script type="text/javascript" src="/javascript/alm-min.js?v=Y5gm6B0b4Kx2YHNObNrgEeBgXlY"></script>
<script type="text/javascript" src="/javascript/taxonomy-browser-min.js?v=vBVMuDMYkGJCXIUxLe35GoyiJNw"></script>
<script type="text/javascript" src="/javascript/jquery.filterize-min.js?v=j0ZKVnHyk2nhFy8eIuNJkp7xaM0"></script>
<script type="text/javascript" src="/javascript/plosone-min.js?v=TK4H4arL_XBSwwJq+K1N3kqYfAI"></script>
<script type="text/javascript" src="/javascript/twitter-min.js?v=xKgcxLsQFXy+at1ao1NVke8nFlM"></script>
<script type="text/javascript" src="/javascript/crossmark.1.4-min.js?v=3FO4k0SjwTaGNnKGNSqthar1080"></script>
<script type="text/javascript">
  var _sf_async_config={uid:16579,domain:"plosone.org"};
  (function(){
    function loadChartbeat() {
      window._sf_endpt=(new Date()).getTime();
      var e = document.createElement('script');
      e.setAttribute('language', 'javascript');
      e.setAttribute('type', 'text/javascript');
      e.setAttribute('src',
          (("https:" == document.location.protocol) ? "https://a248.e.akamai.net/chartbeat.download.akamai.com/102508/" : "http://static.chartbeat.com/") +
              "js/chartbeat.js");
      document.body.appendChild(e);
    }
    var oldonload = window.onload;
    window.onload = (typeof window.onload != 'function') ?
        loadChartbeat : function() { oldonload(); loadChartbeat(); };
  })();
</script>
<!-- <script type="application/javascript" src="http://crossmark.crossref.org/javascripts/v1.3/crossmark.min.js"></script> -->

</body>
</html>
